NUAK1
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
T Sites Probabilities
Log-Odds: S Sites / S Background
Log-Odds: T Sites / T Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| A5A3E0 | S939 | Sugiyama | POTEF A26C1B | VALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPE |
| A5A3E0 | Y940 | Sugiyama | POTEF A26C1B | ALDFEQEMATVAsSSSLEKsyELPDGQVItIGNERFRCPEA |
| O14974 | S445 | GPS6|SIGNOR|EPSD|PSP | PPP1R12A MBS MYPT1 | EEERKDEsPATWRLGLRKtGsyGALAEItASKEGQKEKDTA |
| O14974 | S472 | GPS6|SIGNOR|EPSD|PSP | PPP1R12A MBS MYPT1 | ItASKEGQKEKDTAGVTRsAssPRLsssLDNKEKEKDSKGT |
| O14974 | S910 | GPS6|SIGNOR|EPSD|PSP|Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O43823 | S323 | Sugiyama | AKAP8 AKAP95 | RKRKQFQLyEEPDtKLARVDsEGDFsENDDAAGDFRsGDEE |
| O43852 | S44 | Sugiyama | CALU | KKDRVHHEPQLsDKVHNDAQsFDyDHDAFLGAEEAKtFDQL |
| O60285 | S266 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | LVYGTMPFDGFDHKNLIRQIsSGEYREPTQPSDARGLIRWM |
| O60285 | S313 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | RRATIEDIANHWWVNWGYKSsVCDCDALHDsEsPLLARIID |
| O60285 | S323 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | HWWVNWGYKSsVCDCDALHDsEsPLLARIIDWHHRSTGLQA |
| O60285 | S325 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | WVNWGYKSsVCDCDALHDsEsPLLARIIDWHHRSTGLQADT |
| O60285 | S358 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | STGLQADTEAKMKGLAKPtTsEVMLERQRSLKKSKKENDFA |
| O60285 | S380 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | VMLERQRSLKKSKKENDFAQsGQDAVPEsPsKLSSKRPKGI |
| O60285 | S388 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | LKKSKKENDFAQsGQDAVPEsPsKLSSKRPKGILKKRSNSE |
| O60285 | S390 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | KSKKENDFAQsGQDAVPEsPsKLSSKRPKGILKKRSNSEHR |
| O60285 | S444 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | ALPSTFKMEQDLCRTGVLLPssPEAEVPGKLsPKQSATMPK |
| O60285 | S445 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | LPSTFKMEQDLCRTGVLLPssPEAEVPGKLsPKQSATMPKK |
| O60285 | S455 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | LCRTGVLLPssPEAEVPGKLsPKQSATMPKKGILKKTQQRE |
| O60285 | T356 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | HRSTGLQADTEAKMKGLAKPtTsEVMLERQRSLKKSKKEND |
| O60285 | T60 | Sugiyama | NUAK1 ARK5 KIAA0537 OMPHK1 | HGVKRHHHKHNLKHRYELQEtLGKGTYGKVKRATERFSGRV |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95297 | S260 | Sugiyama | MPZL1 PZR UNQ849/PRO1787 | IyAQLDHsGGHHSDKINKSEsVVyADIRKN___________ |
| O95678 | S162 | Sugiyama | KRT75 K6HF KB18 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| O95835 | S464 | GPS6|SIGNOR|EPSD|PSP | LATS1 WARTS | SPSSGHEIPTWQPNIPVRsNsFNNPLGNRASHSANSQPSAT |
| P00338 | S161 | Sugiyama | LDHA PIG19 | DILTYVAWKISGFPKNRVIGsGCNLDsARFRyLMGERLGVH |
| P00338 | S319 | Sugiyama | LDHA PIG19 | GISDLVKVTLtsEEEARLKKsADtLWGIQKELQF_______ |
| P02538 | S176 | Sugiyama | KRT6A K6A KRT6D | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWT |
| P02545 | S295 | Sugiyama | LMNA LMN1 | RQsAERNsNLVGAAHEELQQsRIRIDsLsAQLsQLQKQLAA |
| P04075 | S36 | Sugiyama | ALDOA ALDA | LsDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENR |
| P04259 | S176 | Sugiyama | KRT6B K6B KRTL1 | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04406 | T237 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | VGKVIPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDD |
| P04637 | S15 | GPS6|SIGNOR|EPSD|PSP | TP53 P53 | ______MEEPQsDPsVEPPLsQEtFsDLWKLLPENNVLsPL |
| P04637 | S392 | GPS6|SIGNOR|EPSD|PSP | TP53 P53 | KKGQstsRHKKLMFKtEGPDsD___________________ |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05198 | S219 | Sugiyama | EIF2S1 EIF2A | CYGYEGIDAVKEALRAGLNCsTENMPIKINLIAPPRYVMTT |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P05787 | S104 | Sugiyama | KRT8 CYK8 | IQAVRTQEKEQIKTLNNKFAsFIDKVRFLEQQNKMLETKWS |
| P06733 | S27 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | HAREIFDsRGNPtVEVDLFtsKGLFRAAVPsGAstGIyEAL |
| P06733 | T205 | Sugiyama | ENO1 ENO1L1 MBPB1 MPB1 | GAEVyHNLKNVIKEKyGKDAtNVGDEGGFAPNILENKEGLE |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07195 | T323 | Sugiyama | LDHB | sVINQKLKDDEVAQLKKsADtLWDIQKDLKDL_________ |
| P07237 | S439 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | NIVIAKMDstANEVEAVKVHsFPtLKFFPAsADRtVIDyNG |
| P07237 | T442 | Sugiyama | P4HB ERBA2L PDI PDIA1 PO4DB | IAKMDstANEVEAVKVHsFPtLKFFPAsADRtVIDyNGERt |
| P07864 | S161 | Sugiyama | LDHC LDH3 LDHX | DILTYIVWKISGLPVTRVIGsGCNLDsARFRYLIGEKLGVH |
| P07900 | S470 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | HEDsQNRKKLsELLRyytsAsGDEMVsLKDYCTRMKENQKH |
| P07900 | S52 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | LIINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDs |
| P07900 | S53 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | IINtFySNKEIFLRELIsNssDALDKIRyEsLtDPsKLDsG |
| P07900 | T317 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | WtRNPDDItNEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08238 | S462 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | HEDstNRRRLsELLRyHtsQsGDEMtsLsEyVsRMKEtQKs |
| P08238 | S48 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | IINTFYSNKEIFLRELIsNAsDALDKIRyEsLtDPsKLDsG |
| P08238 | T309 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | WtRNPDDItQEEyGEFyKsLtNDWEDHLAVKHFSVEGQLEF |
| P08729 | S104 | Sugiyama | KRT7 SCL | LQRVRQEESEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWT |
| P0DPH7 | T41 | Sugiyama | TUBA3C TUBA2 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P12004 | S172 | Sugiyama | PCNA | sHIGDAVVIsCAKDGVKFSAsGELGNGNIKLSQTSNVDKEE |
| P12035 | S211 | Sugiyama | KRT3 | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWN |
| P13647 | S181 | Sugiyama | KRT5 | IQRVRTEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P13798 | S187 | Sugiyama | APEH D3F15S2 D3S48E DNF15S2 | EKKRPKAEsFFQTKALDVsAsDDEIARLKKPDQAIKGDQFV |
| P14625 | S109 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | IINSLYKNKEIFLRELIsNAsDALDKIRLISLTDENALSGN |
| P14625 | T171 | Sugiyama | HSP90B1 GRP94 HSPC4 TRA1 | GVGMtREELVKNLGTIAKsGtsEFLNKMTEAQEDGQSTSEL |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P18754 | S85 | Sugiyama | RCC1 CHC1 | IPEDVVQAEAGGMHTVCLSKsGQVysFGCNDEGALGRDtsV |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P22626 | S189 | Sugiyama | HNRNPA2B1 HNRPA2B1 | IVLQKyHtINGHNAEVRKALsRQEMQEVQssRsGRGGNFGF |
| P23588 | S122 | Sugiyama | EIF4B | NLPyDVTEESIKEFFRGLNIsAVRLPREPsNPERLKGFGyA |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P30622 | S973 | Sugiyama | CLIP1 CYLN1 RSN | LKERDVEELQLKLTKANENAsFLQKSIEDMTVKAEQSQQEA |
| P31943 | S23 | Sugiyama | HNRNPH1 HNRPH HNRPH1 | LGTEGGEGFVVKVRGLPWsCsADEVQRFFSDCKIQNGAQGI |
| P32119 | T142 | Sugiyama | PRDX2 NKEFB TDPX1 | EGIAYRGLFIIDGKGVLRQItVNDLPVGRsVDEALRLVQAF |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P35579 | S1713 | Sugiyama | MYH9 | ERAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQ |
| P35579 | S1714 | Sugiyama | MYH9 | RAKRQAQQERDELADEIANssGKGALALEEKRRLEARIAQL |
| P35579 | S1892 | Sugiyama | MYH9 | LKQLKRQLEEAEEEAQRANAsRRKLQRELEDAtEtADAMNR |
| P35908 | S191 | Sugiyama | KRT2 KRT2A KRT2E | IQNVKAQEREQIKTLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P38936 | S146 | PSP | CDKN1A CAP20 CDKN1 CIP1 MDA6 PIC1 SDI1 WAF1 | QAEGsPGGPGDSQGRKRRQtsMTDFYHsKRRLIFSKRKP__ |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P42677 | S78 | Sugiyama | RPS27 MPS1 | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| P43243 | S188 | Sugiyama | MATR3 KIAA0723 | EPPyRVPRDDWEEKRHFRRDsFDDRGPsLNPVLDyDHGsRs |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46777 | S224 | Sugiyama | RPL5 MSTP030 | VADyMRyLMEEDEDAyKKQFsQyIKNsVtPDMMEEMyKKAH |
| P48637 | S276 | Sugiyama | GSS | VDGQEIAVVYFRDGYMPRQYsLQNWEARLLLERSHAAKCPD |
| P48668 | S176 | Sugiyama | KRT6C KRT6E | IQRVRAEEREQIKTLNNKFAsFIDKVRFLEQQNKVLDTKWT |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P52597 | S63 | Sugiyama | HNRNPF HNRPF | VHFIYTREGRQsGEAFVELGsEDDVKMALKKDRESMGHRyI |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54252 | S260 | Sugiyama | ATXN3 ATX3 MJD MJD1 SCA3 | IDMEDEEADLRRAIQLsMQGssRNIsQDMtQtsGTNLTSEE |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P55212 | S257 | GPS6|SIGNOR|ELM|iPTMNet|EPSD|PSP | CASP6 MCH2 | GKYGSSLEFTELLTLVNRKVsQRRVDFCKDPSAIGKKQVPC |
| P60709 | S239 | Sugiyama | ACTB | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P60709 | Y240 | Sugiyama | ACTB | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P61247 | S236 | Sugiyama | RPS3A FTE1 MFTL | KMLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGy |
| P61247 | S237 | Sugiyama | RPS3A FTE1 MFTL | MLKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyE |
| P61247 | S238 | Sugiyama | RPS3A FTE1 MFTL | LKKPKFELGKLMELHGEGsssGKAtGDEtGAKVERADGyEP |
| P61313 | S97 | Sugiyama | RPL15 EC45 TCBAP0781 | KGAtyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLN |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62277 | S14 | Sugiyama | RPS13 | _______MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDDVK |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S241 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P62736 | Y242 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P63261 | S239 | Sugiyama | ACTG1 ACTG | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63261 | Y240 | Sugiyama | ACTG1 ACTG | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| P63267 | S240 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P63267 | Y241 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68032 | S241 | Sugiyama | ACTC1 ACTC | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68032 | Y242 | Sugiyama | ACTC1 ACTC | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68133 | S241 | Sugiyama | ACTA1 ACTA | VALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| P68133 | Y242 | Sugiyama | ACTA1 ACTA | ALDFENEMAtAAssssLEKsyELPDGQVItIGNERFRCPET |
| P68363 | T41 | Sugiyama | TUBA1B | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| P83731 | S38 | Sugiyama | RPL24 | GRRYARTDGKVFQFLNAKCEsAFLSKRNPRQINWtVLyRRK |
| P83731 | S7 | Sugiyama | RPL24 | ______________MKVELCsFsGyKIYPGHGRRYARTDGK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S37 | Sugiyama | RPL19 | CGKKKVWLDPNEtNEIANANsRQQIRKLIKDGLIIRKPVtV |
| P84098 | T29 | Sugiyama | RPL19 | RLAssVLRCGKKKVWLDPNEtNEIANANsRQQIRKLIKDGL |
| Q01082 | S1388 | Sugiyama | SPTBN1 SPTB2 | TTQTKAQRLFDANKAELFtQsCADLDKWLHGLESQIQSDDy |
| Q01105 | S161 | Sugiyama | SET | FDENPyFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTK |
| Q01105 | S166 | Sugiyama | SET | yFENKVLSKEFHLNEsGDPssKstEIKWKSGKDLTKRssQT |
| Q01546 | S196 | Sugiyama | KRT76 KRT2B KRT2P | IGQVKAQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWE |
| Q06210 | S261 | Sugiyama | GFPT1 GFAT GFPT | GsQGERGKDKKGSCNLsRVDsttCLFPVEEKAVEyyFASDA |
| Q06830 | T143 | Sugiyama | PRDX1 PAGA PAGB TDPX2 | EGIsFRGLFIIDDKGILRQItVNDLPVGRsVDEtLRLVQAF |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09028 | S147 | Sugiyama | RBBP4 RBAP48 | VNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGEC |
| Q13263 | S471 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | FGsGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLE |
| Q13263 | S473 | Sugiyama | TRIM28 KAP1 RNF96 TIF1B | sGDDPyssAEPHVsGVKRsRsGEGEVsGLMRKVPRVsLERL |
| Q14152 | S492 | Sugiyama | EIF3A EIF3S10 KIAA0139 | VDAARHCDLQVRIDHTSRTLsFGsDLNyAtREDAPIGPHLQ |
| Q14568 | S52 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | LIINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDS |
| Q14568 | S53 | Sugiyama | HSP90AA2P HSP90AA2 HSPC2 HSPCAL3 | IINTFYSNKEIFLRELIsNssDALDKIWYESLTDPSKLDSG |
| Q14CN4 | S138 | Sugiyama | KRT72 K6IRS2 KB35 KRT6 KRT6IRS2 | IQRVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWN |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q16513 | T958 | Sugiyama | PKN2 PRK2 PRKCL2 | RGREDVSNFDDEFtsEAPILtPPREPRILsEEEQEMFRDFD |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q16576 | S146 | Sugiyama | RBBP7 RBAP46 | VNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGEC |
| Q16658 | S237 | Sugiyama | FSCN1 FAN1 HSN SNL | RsGKVAFRDCEGRyLAPsGPsGtLKAGKATKVGKDELFALE |
| Q3SY84 | S143 | Sugiyama | KRT71 K6IRS1 KB34 KRT6IRS1 | IQKVRAQEREQIKALNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q562R1 | S240 | Sugiyama | ACTBL2 | VALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPE |
| Q562R1 | Y241 | Sugiyama | ACTBL2 | ALDFEQEMVRAAAssSPERsyELPDGQVItIGNERFRCPEA |
| Q5H9R7 | S579 | Sugiyama | PPP6R3 C11orf23 KIAA1558 PP6R3 SAPL SAPS3 | IDQFGFNDEKFADQDDIGNVsFDRVSDINFTLNTNESGNIA |
| Q5T035 | S66 | Sugiyama | FAM120A2P C9orf129 | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERSLPI |
| Q5XKE5 | S155 | Sugiyama | KRT79 K6L KB38 KRT6L | IQRVRTQEREQIKTLNNKFAsFIDKVRFLEQQNKVLETKWA |
| Q6FI81 | S305 | Sugiyama | CIAPIN1 CUA001 PRO0915 | CAsCPyLGMPAFKPGEKVLLsDsNLHDA_____________ |
| Q6GYQ0 | S797 | Sugiyama | RALGAPA1 GARNL1 KIAA0884 TULIP1 | EtGNEVFGALNEEQPLPRssstsDILEPFTVERAKVNKEDM |
| Q6PEY2 | T41 | Sugiyama | TUBA3E | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q6S8J3 | S939 | Sugiyama | POTEE A26C1A POTE2 | VALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPE |
| Q6S8J3 | Y940 | Sugiyama | POTEE A26C1A POTE2 | ALDFEQEMAtAAssssLEKsyELPDGQVItIGNERFRCPEA |
| Q6ZMR3 | S161 | Sugiyama | LDHAL6A LDHL2 | DILTYVAWKLSGFPKNRVIGsGCNLDsARFRYFIGQRLGIH |
| Q71U36 | T41 | Sugiyama | TUBA1A TUBA3 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q71UM5 | S78 | Sugiyama | RPS27L | GCSTVLCQPTGGKARLtEGCsFRRKQH______________ |
| Q7RTS7 | S153 | Sugiyama | KRT74 K6IRS4 KB37 KRT5C KRT6IRS4 | IQKVRAQEREQIKVLNDKFAsFIDKVRFLEQQNQVLETKWE |
| Q7Z2W4 | S492 | Sugiyama | ZC3HAV1 ZC3HDC2 PRO1677 | VQATGRIADDADPRVALVNDsLsDVtsTtssRVDDHDSEEI |
| Q7Z794 | S177 | Sugiyama | KRT77 KRT1B | IQRIKTQEREQIMVLNNKFAsFIDKVRFLEQQNQVLQTKWE |
| Q86Y46 | S145 | Sugiyama | KRT73 K6IRS3 KB36 KRT6IRS3 | IQKVRAQEREQIKVLNNKFAsFIDKVRFLEQQNQVLETKWE |
| Q8N806 | S265 | Sugiyama | UBR7 C14orf130 | KDDVREVKVEQNsEPCAGsssEsDLQtVFKNESLNAESKSG |
| Q8NBP7 | S488 | Sugiyama | PCSK9 NARC1 PSEC0052 | TRMATAVARCAPDEELLsCssFSRSGKRRGERMEAQGGKLV |
| Q8TDD1 | S581 | Sugiyama | DDX54 | RLVDSIKNYRSRATIFEINAsSRDLCsQVMRAKRQKDRKAI |
| Q96HC4 | S362 | Sugiyama | PDLIM5 ENH L9 | SLTAAAAFKPVGStGVIKsPsWQRPNQGVPstGRIsNsAtY |
| Q96IZ0 | S259 | Sugiyama | PAWR PAR4 | SRYsRTDRSGFPRYNRDANVsGtLVSSstLEKKIEDLEKEV |
| Q96N67 | S1432 | Sugiyama | DOCK7 KIAA1771 | RRSRGQLGTYTIAsPPERsPsGsAFGsQENLRWRKDMTHWR |
| Q9BQE3 | T41 | Sugiyama | TUBA1C TUBA6 | WELYCLEHGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKH |
| Q9BYX7 | S239 | Sugiyama | POTEKP ACTBL3 FKSG30 | VALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPE |
| Q9BYX7 | Y240 | Sugiyama | POTEKP ACTBL3 FKSG30 | ALDSEQEMAMAASSSSVEKsyELPDGQVItIGNERFRCPEA |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9HA92 | S173 | Sugiyama | RSAD1 | LSIGLQSLDDTELRLLGRtHsACDALRTLAEARRLFPGRVS |
| Q9HA92 | T171 | Sugiyama | RSAD1 | NRLSIGLQSLDDTELRLLGRtHsACDALRTLAEARRLFPGR |
| Q9NSB2 | S178 | Sugiyama | KRT84 KRTHB4 | AQRVKKDEKEQIKTLNNKFAsFIDKVRFLEQQNKLLETKWS |
| Q9NYB9 | S22 | Sugiyama | ABI2 ARGBPIA | AELQMLLEEEIPGGRRALFDsytNLERVADyCENNyIQSAD |
| Q9NZB2 | S417 | Sugiyama | FAM120A C9orf10 KIAA0183 OSSA | LSEPAPLTLDTSGKNLtEQNsysNIPHEGKHtPLyERssPI |
| Q9UII2 | S63 | Sugiyama | ATP5IF1 ATPI ATPIF1 | AGGAFGKREQAEEERyFRAQsREQLAALKKHHEEEIVHHKK |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9Y2B0 | S55 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDELEWEIAQVDPKKTIQMGsFRINPDGsQsVVEVPyARsE |
| Q9Y2B0 | S65 | Sugiyama | CNPY2 MSAP TMEM4 ZSIG9 UNQ1943/PRO4426 | VDPKKTIQMGsFRINPDGsQsVVEVPyARsEAHLtELLEEI |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Signal Transduction | R-HSA-162582 | 4.633078e-09 | 8.334 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 1.344187e-07 | 6.872 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.035919e-07 | 6.691 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 9.905601e-07 | 6.004 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 4.403002e-06 | 5.356 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 2.065792e-05 | 4.685 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 3.162902e-05 | 4.500 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 4.551097e-05 | 4.342 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 5.572940e-05 | 4.254 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 5.642691e-05 | 4.249 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 9.004174e-05 | 4.046 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.013785e-04 | 3.994 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 1.322373e-04 | 3.879 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 1.817437e-04 | 3.741 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 1.938594e-04 | 3.713 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 2.225790e-04 | 3.653 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.384796e-04 | 3.623 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 2.379090e-04 | 3.624 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 2.636361e-04 | 3.579 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 3.601789e-04 | 3.443 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.087810e-04 | 3.389 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 4.261946e-04 | 3.370 | 0 | 0 |
| Kinesins | R-HSA-983189 | 4.243699e-04 | 3.372 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 4.314278e-04 | 3.365 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 4.567522e-04 | 3.340 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 6.048692e-04 | 3.218 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 6.704987e-04 | 3.174 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 7.091210e-04 | 3.149 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 7.781925e-04 | 3.109 | 0 | 0 |
| M Phase | R-HSA-68886 | 7.800655e-04 | 3.108 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 7.214130e-04 | 3.142 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 6.722783e-04 | 3.172 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 8.224833e-04 | 3.085 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 8.224833e-04 | 3.085 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 7.282547e-04 | 3.138 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 8.472038e-04 | 3.072 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 8.472038e-04 | 3.072 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.741213e-04 | 3.058 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 1.022464e-03 | 2.990 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.038516e-03 | 2.984 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 1.184797e-03 | 2.926 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.184797e-03 | 2.926 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.090393e-03 | 2.962 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.157380e-03 | 2.937 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 1.184797e-03 | 2.926 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 1.184797e-03 | 2.926 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 1.319750e-03 | 2.880 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 1.361481e-03 | 2.866 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.438480e-03 | 2.842 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 1.552562e-03 | 2.809 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.543888e-03 | 2.811 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 1.654660e-03 | 2.781 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.661523e-03 | 2.779 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 1.991914e-03 | 2.701 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.249473e-03 | 2.648 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.249473e-03 | 2.648 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.423919e-03 | 2.615 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 2.427091e-03 | 2.615 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 2.424704e-03 | 2.615 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 2.493041e-03 | 2.603 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 2.602773e-03 | 2.585 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 2.602773e-03 | 2.585 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 2.881347e-03 | 2.540 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 2.881347e-03 | 2.540 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 2.881347e-03 | 2.540 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 2.881347e-03 | 2.540 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 2.834768e-03 | 2.547 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.743766e-03 | 2.562 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 2.779914e-03 | 2.556 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 2.780531e-03 | 2.556 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 2.886969e-03 | 2.540 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.213718e-03 | 2.493 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 3.390078e-03 | 2.470 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 3.419424e-03 | 2.466 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.492843e-03 | 2.457 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.846659e-03 | 2.415 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 3.931158e-03 | 2.405 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 4.151141e-03 | 2.382 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 4.555413e-03 | 2.341 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 5.340736e-03 | 2.272 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.224111e-03 | 2.282 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.414216e-03 | 2.266 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 5.789759e-03 | 2.237 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 5.924680e-03 | 2.227 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.131897e-03 | 2.212 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 6.220746e-03 | 2.206 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.875479e-03 | 2.163 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 6.738392e-03 | 2.171 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 6.911520e-03 | 2.160 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 6.973032e-03 | 2.157 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 6.973032e-03 | 2.157 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 6.973032e-03 | 2.157 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 6.973032e-03 | 2.157 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 7.019701e-03 | 2.154 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.592341e-03 | 2.120 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 7.751586e-03 | 2.111 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 7.880106e-03 | 2.103 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.085527e-03 | 2.092 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 8.152362e-03 | 2.089 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 8.836708e-03 | 2.054 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 8.836708e-03 | 2.054 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 8.836708e-03 | 2.054 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 8.836708e-03 | 2.054 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 8.371704e-03 | 2.077 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 8.854081e-03 | 2.053 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 8.983774e-03 | 2.047 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.029029e-03 | 2.044 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 9.114550e-03 | 2.040 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 9.170811e-03 | 2.038 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 9.874175e-03 | 2.005 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 9.776608e-03 | 2.010 | 1 | 1 |
| Signaling by Interleukins | R-HSA-449147 | 9.244692e-03 | 2.034 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 9.923453e-03 | 2.003 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.033460e-02 | 1.986 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.068845e-02 | 1.971 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.068845e-02 | 1.971 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 1.141076e-02 | 1.943 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 1.109623e-02 | 1.955 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 1.163728e-02 | 1.934 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 1.163977e-02 | 1.934 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 1.163977e-02 | 1.934 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 1.112008e-02 | 1.954 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.177596e-02 | 1.929 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.243672e-02 | 1.905 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 1.273737e-02 | 1.895 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.281220e-02 | 1.892 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.332517e-02 | 1.875 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.341534e-02 | 1.872 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 1.373853e-02 | 1.862 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 1.669544e-02 | 1.777 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 1.669544e-02 | 1.777 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 1.669544e-02 | 1.777 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 1.669544e-02 | 1.777 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 1.669544e-02 | 1.777 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 1.669544e-02 | 1.777 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 1.669544e-02 | 1.777 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 1.669544e-02 | 1.777 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 1.669544e-02 | 1.777 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 1.669544e-02 | 1.777 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 1.669544e-02 | 1.777 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 1.669544e-02 | 1.777 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.597999e-02 | 1.796 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.609689e-02 | 1.793 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.593170e-02 | 1.798 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.593170e-02 | 1.798 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.567881e-02 | 1.805 | 1 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 1.609689e-02 | 1.793 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 1.535349e-02 | 1.814 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.652887e-02 | 1.782 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 1.477694e-02 | 1.830 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.652887e-02 | 1.782 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 1.673494e-02 | 1.776 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 1.849506e-02 | 1.733 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 1.863411e-02 | 1.730 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.112057e-02 | 1.675 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.112057e-02 | 1.675 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 2.112057e-02 | 1.675 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 2.112057e-02 | 1.675 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 2.112057e-02 | 1.675 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 2.112057e-02 | 1.675 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 2.112057e-02 | 1.675 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 2.112057e-02 | 1.675 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 1.994978e-02 | 1.700 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 2.134308e-02 | 1.671 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 2.276632e-02 | 1.643 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 2.297945e-02 | 1.639 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 2.297945e-02 | 1.639 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 2.297945e-02 | 1.639 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 2.304095e-02 | 1.637 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 2.304095e-02 | 1.637 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 2.196479e-02 | 1.658 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.176689e-02 | 1.662 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.326263e-02 | 1.633 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 2.190267e-02 | 1.660 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.314002e-02 | 1.636 | 1 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 2.390113e-02 | 1.622 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 2.164326e-02 | 1.665 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.212774e-02 | 1.655 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.196479e-02 | 1.658 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 2.297945e-02 | 1.639 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 2.305791e-02 | 1.637 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 2.391586e-02 | 1.621 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 2.420229e-02 | 1.616 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 2.441678e-02 | 1.612 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.444731e-02 | 1.612 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 2.444731e-02 | 1.612 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.444731e-02 | 1.612 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.516078e-02 | 1.599 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 2.535704e-02 | 1.596 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.570237e-02 | 1.590 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 2.614726e-02 | 1.583 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 2.632685e-02 | 1.580 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 2.940837e-02 | 1.532 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 2.940837e-02 | 1.532 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 2.727690e-02 | 1.564 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.727690e-02 | 1.564 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 2.727690e-02 | 1.564 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 2.727690e-02 | 1.564 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 2.914022e-02 | 1.536 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 2.677498e-02 | 1.572 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.688220e-02 | 1.571 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 2.962230e-02 | 1.528 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 2.806820e-02 | 1.552 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 2.846509e-02 | 1.546 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.966996e-02 | 1.528 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 3.081712e-02 | 1.511 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.086710e-02 | 1.511 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 3.086710e-02 | 1.511 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.154766e-02 | 1.501 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 3.270891e-02 | 1.485 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 3.314554e-02 | 1.480 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 3.318697e-02 | 1.479 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.564962e-02 | 1.448 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 3.564962e-02 | 1.448 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 3.564962e-02 | 1.448 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 3.786231e-02 | 1.422 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 3.551783e-02 | 1.450 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.698032e-02 | 1.432 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.831149e-02 | 1.417 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 3.458170e-02 | 1.461 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 3.564962e-02 | 1.448 | 0 | 0 |
| PKA activation | R-HSA-163615 | 3.564962e-02 | 1.448 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 3.564962e-02 | 1.448 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 3.786231e-02 | 1.422 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.786231e-02 | 1.422 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.907463e-02 | 1.408 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 3.458170e-02 | 1.461 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 3.425834e-02 | 1.465 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 3.786231e-02 | 1.422 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.812115e-02 | 1.419 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 3.757841e-02 | 1.425 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 3.921320e-02 | 1.407 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.934658e-02 | 1.405 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 4.005877e-02 | 1.397 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.026808e-02 | 1.395 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 4.026808e-02 | 1.395 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 4.026808e-02 | 1.395 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 4.026808e-02 | 1.395 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 4.026808e-02 | 1.395 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.056752e-02 | 1.392 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 4.056752e-02 | 1.392 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.190485e-02 | 1.378 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 4.212445e-02 | 1.375 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.288888e-02 | 1.368 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 4.355036e-02 | 1.361 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.382085e-02 | 1.358 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 4.653368e-02 | 1.332 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.653368e-02 | 1.332 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 4.540821e-02 | 1.343 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 4.540821e-02 | 1.343 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 5.243432e-02 | 1.280 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.138334e-02 | 1.289 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 5.138334e-02 | 1.289 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 4.920702e-02 | 1.308 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 4.496673e-02 | 1.347 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.579536e-02 | 1.339 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 4.789418e-02 | 1.320 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 5.157819e-02 | 1.288 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 5.243432e-02 | 1.280 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 4.979238e-02 | 1.303 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 4.703323e-02 | 1.328 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 4.986474e-02 | 1.302 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 4.540821e-02 | 1.343 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 4.597222e-02 | 1.338 | 1 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 5.211237e-02 | 1.283 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 4.789418e-02 | 1.320 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 5.204516e-02 | 1.284 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.769642e-02 | 1.322 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 5.122938e-02 | 1.290 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 5.122938e-02 | 1.290 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 5.276724e-02 | 1.278 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 5.357240e-02 | 1.271 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 5.357240e-02 | 1.271 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 5.465290e-02 | 1.262 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 5.517224e-02 | 1.258 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.660481e-02 | 1.247 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 5.863690e-02 | 1.232 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 5.863690e-02 | 1.232 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 5.980647e-02 | 1.223 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.014177e-02 | 1.221 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.014177e-02 | 1.221 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.014177e-02 | 1.221 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 6.014177e-02 | 1.221 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 6.015656e-02 | 1.221 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.042742e-02 | 1.219 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 6.073618e-02 | 1.217 | 0 | 0 |
| Transport of glycerol from adipocytes to the liver by Aquaporins | R-HSA-432030 | 6.073618e-02 | 1.217 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 6.073618e-02 | 1.217 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 6.132294e-02 | 1.212 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.296662e-02 | 1.201 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 6.365781e-02 | 1.196 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 6.376892e-02 | 1.195 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 6.376892e-02 | 1.195 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 6.382356e-02 | 1.195 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 6.400096e-02 | 1.194 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.532831e-02 | 1.185 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 6.548708e-02 | 1.184 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 6.567131e-02 | 1.183 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 6.567855e-02 | 1.183 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.567855e-02 | 1.183 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 6.722530e-02 | 1.172 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 6.722530e-02 | 1.172 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.710015e-02 | 1.113 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.710015e-02 | 1.113 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.710015e-02 | 1.113 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.710015e-02 | 1.113 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 7.583755e-02 | 1.120 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 7.887223e-02 | 1.103 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 6.691531e-02 | 1.174 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 6.691531e-02 | 1.174 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 7.786702e-02 | 1.109 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 7.377877e-02 | 1.132 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 6.722530e-02 | 1.172 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.583755e-02 | 1.120 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 7.887223e-02 | 1.103 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 6.971278e-02 | 1.157 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 7.106666e-02 | 1.148 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 6.616078e-02 | 1.179 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.710015e-02 | 1.113 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 7.511338e-02 | 1.124 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 7.913939e-02 | 1.102 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 8.058128e-02 | 1.094 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 8.260949e-02 | 1.083 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 8.473262e-02 | 1.072 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 8.615758e-02 | 1.065 | 1 | 0 |
| Heme signaling | R-HSA-9707616 | 8.744796e-02 | 1.058 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.824459e-02 | 1.054 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 8.824459e-02 | 1.054 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 8.835635e-02 | 1.054 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 8.866510e-02 | 1.052 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 8.866510e-02 | 1.052 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 8.868155e-02 | 1.052 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.908877e-02 | 1.050 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.119471e-02 | 1.040 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 9.136082e-02 | 1.039 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.167614e-02 | 1.038 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.167614e-02 | 1.038 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 9.167614e-02 | 1.038 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 9.332700e-02 | 1.030 | 1 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 9.351771e-02 | 1.029 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 9.351771e-02 | 1.029 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 9.427445e-02 | 1.026 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.440977e-02 | 1.025 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.441872e-02 | 1.025 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 9.472008e-02 | 1.024 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 9.472008e-02 | 1.024 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 9.921107e-02 | 1.003 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 9.921107e-02 | 1.003 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 9.921107e-02 | 1.003 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 9.921107e-02 | 1.003 | 0 | 0 |
| TWIK related potassium channel (TREK) | R-HSA-1299503 | 9.921107e-02 | 1.003 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 1.185227e-01 | 0.926 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.185227e-01 | 0.926 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.106327e-01 | 0.956 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.106327e-01 | 0.956 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 1.073843e-01 | 0.969 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.760541e-02 | 1.011 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.760541e-02 | 1.011 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 1.096830e-01 | 0.960 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 1.096830e-01 | 0.960 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 1.103610e-01 | 0.957 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 1.039487e-01 | 0.983 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 9.618054e-02 | 1.017 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.025442e-01 | 0.989 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 1.142982e-01 | 0.942 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 1.170749e-01 | 0.932 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 1.096830e-01 | 0.960 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 1.031258e-01 | 0.987 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.103610e-01 | 0.957 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 1.073843e-01 | 0.969 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 1.074166e-01 | 0.969 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 1.115642e-01 | 0.952 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 1.179757e-01 | 0.928 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 9.917992e-02 | 1.004 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 9.957253e-02 | 1.002 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 1.096830e-01 | 0.960 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.088553e-01 | 0.963 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 9.508686e-02 | 1.022 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 9.508686e-02 | 1.022 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.106327e-01 | 0.956 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 1.096830e-01 | 0.960 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 9.618054e-02 | 1.017 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 1.154194e-01 | 0.938 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 9.836914e-02 | 1.007 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 1.214145e-01 | 0.916 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 1.221432e-01 | 0.913 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.225371e-01 | 0.912 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.225371e-01 | 0.912 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.225371e-01 | 0.912 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.232956e-01 | 0.909 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.236786e-01 | 0.908 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.236786e-01 | 0.908 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.236786e-01 | 0.908 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.236786e-01 | 0.908 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.236786e-01 | 0.908 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.239566e-01 | 0.907 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.239566e-01 | 0.907 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.239566e-01 | 0.907 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 1.239566e-01 | 0.907 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 1.291430e-01 | 0.889 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 1.291430e-01 | 0.889 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 1.291430e-01 | 0.889 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 1.298442e-01 | 0.887 | 0 | 0 |
| Drug-mediated inhibition of MET activation | R-HSA-9734091 | 2.325544e-01 | 0.633 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 2.325544e-01 | 0.633 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 2.325544e-01 | 0.633 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 2.325544e-01 | 0.633 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 2.325544e-01 | 0.633 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 2.325544e-01 | 0.633 | 0 | 0 |
| Defective Mismatch Repair Associated With PMS2 | R-HSA-5632987 | 2.325544e-01 | 0.633 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 2.325544e-01 | 0.633 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 2.325544e-01 | 0.633 | 0 | 0 |
| TWIK-related spinal cord K+ channel (TRESK) | R-HSA-1299344 | 2.325544e-01 | 0.633 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH3 | R-HSA-5632927 | 2.325544e-01 | 0.633 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 2.325544e-01 | 0.633 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 2.325544e-01 | 0.633 | 0 | 0 |
| Defective Mismatch Repair Associated With MLH1 | R-HSA-5545483 | 2.325544e-01 | 0.633 | 0 | 0 |
| Defective SLC2A10 causes arterial tortuosity syndrome (ATS) | R-HSA-5619068 | 2.325544e-01 | 0.633 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 1.425815e-01 | 0.846 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 1.425815e-01 | 0.846 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 1.890438e-01 | 0.723 | 0 | 0 |
| HCN channels | R-HSA-1296061 | 1.890438e-01 | 0.723 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 1.890438e-01 | 0.723 | 0 | 0 |
| RUNX3 regulates BCL2L11 (BIM) transcription | R-HSA-8952158 | 1.890438e-01 | 0.723 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.890438e-01 | 0.723 | 0 | 0 |
| Defective LFNG causes SCDO3 | R-HSA-5083630 | 1.890438e-01 | 0.723 | 0 | 0 |
| TGFBR3 regulates FGF2 signaling | R-HSA-9839397 | 3.276954e-01 | 0.485 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 3.276954e-01 | 0.485 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 3.276954e-01 | 0.485 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 3.276954e-01 | 0.485 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 3.276954e-01 | 0.485 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 3.276954e-01 | 0.485 | 0 | 0 |
| MyD88 deficiency (TLR5) | R-HSA-5602680 | 3.276954e-01 | 0.485 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 3.276954e-01 | 0.485 | 0 | 0 |
| Defective POMGNT1 causes MDDGA3, MDDGB3 and MDDGC3 | R-HSA-5083628 | 3.276954e-01 | 0.485 | 0 | 0 |
| XAV939 stabilizes AXIN | R-HSA-5545619 | 3.276954e-01 | 0.485 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 3.276954e-01 | 0.485 | 0 | 0 |
| Defective SLC20A2 causes idiopathic basal ganglia calcification 1 (IBGC1) | R-HSA-5619111 | 3.276954e-01 | 0.485 | 0 | 0 |
| Defective ABCC9 causes CMD10, ATFB12 and Cantu syndrome | R-HSA-5678420 | 3.276954e-01 | 0.485 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 3.276954e-01 | 0.485 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 3.276954e-01 | 0.485 | 0 | 0 |
| Defective PGM1 causes PGM1-CDG | R-HSA-5609974 | 3.276954e-01 | 0.485 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 3.276954e-01 | 0.485 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 3.276954e-01 | 0.485 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 2.371660e-01 | 0.625 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 2.371660e-01 | 0.625 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.371660e-01 | 0.625 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 2.371660e-01 | 0.625 | 0 | 0 |
| G2 Phase | R-HSA-68911 | 2.371660e-01 | 0.625 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.800698e-01 | 0.745 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 1.800698e-01 | 0.745 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 1.645687e-01 | 0.784 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 2.135125e-01 | 0.671 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 2.135125e-01 | 0.671 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 2.858233e-01 | 0.544 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 2.858233e-01 | 0.544 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 2.858233e-01 | 0.544 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.858233e-01 | 0.544 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.858233e-01 | 0.544 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 2.858233e-01 | 0.544 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 2.858233e-01 | 0.544 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 2.858233e-01 | 0.544 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 2.858233e-01 | 0.544 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.858233e-01 | 0.544 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 4.110465e-01 | 0.386 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 4.110465e-01 | 0.386 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 4.110465e-01 | 0.386 | 0 | 0 |
| Defective POMT1 causes MDDGA1, MDDGB1 and MDDGC1 | R-HSA-5083633 | 4.110465e-01 | 0.386 | 0 | 0 |
| Defective POMT2 causes MDDGA2, MDDGB2 and MDDGC2 | R-HSA-5083629 | 4.110465e-01 | 0.386 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 1.489525e-01 | 0.827 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 1.904285e-01 | 0.720 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 1.904285e-01 | 0.720 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 2.481316e-01 | 0.605 | 0 | 0 |
| Activation of Ca-permeable Kainate Receptor | R-HSA-451308 | 2.481316e-01 | 0.605 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 1.699514e-01 | 0.770 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 1.699514e-01 | 0.770 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 1.699514e-01 | 0.770 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 3.341441e-01 | 0.476 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 3.341441e-01 | 0.476 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 3.341441e-01 | 0.476 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 3.341441e-01 | 0.476 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 3.341441e-01 | 0.476 | 0 | 0 |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | R-HSA-629587 | 3.341441e-01 | 0.476 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 1.363330e-01 | 0.865 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.920190e-01 | 0.717 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 1.705221e-01 | 0.768 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 2.835108e-01 | 0.547 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 2.835108e-01 | 0.547 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 1.361458e-01 | 0.866 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.454398e-01 | 0.610 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 2.454398e-01 | 0.610 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.454398e-01 | 0.610 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 2.150270e-01 | 0.668 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 2.150270e-01 | 0.668 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 1.686706e-01 | 0.773 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.504817e-01 | 0.823 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 1.655125e-01 | 0.781 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.859912e-01 | 0.731 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 2.388419e-01 | 0.622 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.741484e-01 | 0.562 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 2.741484e-01 | 0.562 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 2.741484e-01 | 0.562 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 3.192709e-01 | 0.496 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 3.192709e-01 | 0.496 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 3.192709e-01 | 0.496 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.192709e-01 | 0.496 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 3.814644e-01 | 0.419 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 3.814644e-01 | 0.419 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 3.814644e-01 | 0.419 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 3.814644e-01 | 0.419 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 3.814644e-01 | 0.419 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 3.814644e-01 | 0.419 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 3.814644e-01 | 0.419 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 3.814644e-01 | 0.419 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 3.814644e-01 | 0.419 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 3.814644e-01 | 0.419 | 0 | 0 |
| Pre-NOTCH Processing in the Endoplasmic Reticulum | R-HSA-1912399 | 3.814644e-01 | 0.419 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 3.814644e-01 | 0.419 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 3.814644e-01 | 0.419 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 4.840682e-01 | 0.315 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.840682e-01 | 0.315 | 0 | 0 |
| The IPAF inflammasome | R-HSA-844623 | 4.840682e-01 | 0.315 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.840682e-01 | 0.315 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of other transcription factors | R-HSA-8866906 | 4.840682e-01 | 0.315 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.840682e-01 | 0.315 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.840682e-01 | 0.315 | 0 | 0 |
| Defective CYP1B1 causes Glaucoma | R-HSA-5579000 | 4.840682e-01 | 0.315 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.840682e-01 | 0.315 | 0 | 0 |
| Defective HPRT1 disrupts guanine and hypoxanthine salvage | R-HSA-9734281 | 4.840682e-01 | 0.315 | 0 | 0 |
| Defective GCLC causes HAGGSD | R-HSA-5578999 | 4.840682e-01 | 0.315 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.840682e-01 | 0.315 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.840682e-01 | 0.315 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 1.616305e-01 | 0.791 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 2.040051e-01 | 0.690 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 2.040051e-01 | 0.690 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 2.633280e-01 | 0.580 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 2.633280e-01 | 0.580 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 2.633280e-01 | 0.580 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 2.633280e-01 | 0.580 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 1.759778e-01 | 0.755 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 1.975064e-01 | 0.704 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 1.975064e-01 | 0.704 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 3.033725e-01 | 0.518 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 3.033725e-01 | 0.518 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 2.524238e-01 | 0.598 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 3.550724e-01 | 0.450 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 3.550724e-01 | 0.450 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 2.883497e-01 | 0.540 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 2.883497e-01 | 0.540 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.715620e-01 | 0.766 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 2.317859e-01 | 0.635 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 2.744366e-01 | 0.562 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 3.329094e-01 | 0.478 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 4.272898e-01 | 0.369 | 0 | 0 |
| FGFR1b ligand binding and activation | R-HSA-190370 | 4.272898e-01 | 0.369 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 4.272898e-01 | 0.369 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 4.272898e-01 | 0.369 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 4.272898e-01 | 0.369 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 4.272898e-01 | 0.369 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.615769e-01 | 0.582 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 3.137732e-01 | 0.503 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 3.137732e-01 | 0.503 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.485441e-01 | 0.828 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 2.968783e-01 | 0.527 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 2.968783e-01 | 0.527 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 3.906172e-01 | 0.408 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 3.906172e-01 | 0.408 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 3.906172e-01 | 0.408 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 2.817210e-01 | 0.550 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.647077e-01 | 0.783 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 3.196554e-01 | 0.495 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 2.134839e-01 | 0.671 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 3.022266e-01 | 0.520 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 3.022266e-01 | 0.520 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 1.740660e-01 | 0.759 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.724953e-01 | 0.565 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.724953e-01 | 0.565 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 2.263426e-01 | 0.645 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.786791e-01 | 0.748 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.786791e-01 | 0.748 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 3.230236e-01 | 0.491 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 3.653100e-01 | 0.437 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 3.653100e-01 | 0.437 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.256481e-01 | 0.371 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 4.256481e-01 | 0.371 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 4.256481e-01 | 0.371 | 0 | 0 |
| Interleukin-21 signaling | R-HSA-9020958 | 4.712638e-01 | 0.327 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 4.712638e-01 | 0.327 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.166969e-01 | 0.664 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.166969e-01 | 0.664 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 3.911798e-01 | 0.408 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 3.911798e-01 | 0.408 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 3.094478e-01 | 0.509 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.599469e-01 | 0.337 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 4.599469e-01 | 0.337 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 4.599469e-01 | 0.337 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.599469e-01 | 0.337 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 4.169664e-01 | 0.380 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 5.131413e-01 | 0.290 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 5.131413e-01 | 0.290 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 4.425663e-01 | 0.354 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.714193e-01 | 0.430 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 3.990812e-01 | 0.399 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 3.438691e-01 | 0.464 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 4.678846e-01 | 0.330 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 4.584089e-01 | 0.339 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 3.119187e-01 | 0.506 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.089518e-01 | 0.388 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 5.256587e-01 | 0.279 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 5.173402e-01 | 0.286 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.010744e-01 | 0.300 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.975327e-01 | 0.303 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 2.942607e-01 | 0.531 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 1.735942e-01 | 0.760 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.705712e-01 | 0.768 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.080385e-01 | 0.682 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.446656e-01 | 0.840 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.080385e-01 | 0.682 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 4.473395e-01 | 0.349 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 3.625688e-01 | 0.441 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 3.077011e-01 | 0.512 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 4.711415e-01 | 0.327 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 2.150270e-01 | 0.668 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 1.908815e-01 | 0.719 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 4.123151e-01 | 0.385 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 5.071005e-01 | 0.295 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 4.599469e-01 | 0.337 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.250963e-01 | 0.372 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 2.329428e-01 | 0.633 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.961872e-01 | 0.402 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 2.481316e-01 | 0.605 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 3.137732e-01 | 0.503 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.095272e-01 | 0.509 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 4.933327e-01 | 0.307 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.440427e-01 | 0.463 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 3.329094e-01 | 0.478 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 2.228897e-01 | 0.652 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 4.865130e-01 | 0.313 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 3.429288e-01 | 0.465 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.268715e-01 | 0.278 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 1.482505e-01 | 0.829 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.411108e-01 | 0.850 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 1.705712e-01 | 0.768 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 3.329094e-01 | 0.478 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 4.169664e-01 | 0.380 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 5.256587e-01 | 0.279 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 4.678846e-01 | 0.330 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 4.901531e-01 | 0.310 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 1.489525e-01 | 0.827 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 1.920190e-01 | 0.717 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 3.438521e-01 | 0.464 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 3.438521e-01 | 0.464 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.921868e-01 | 0.534 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 5.131413e-01 | 0.290 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.883562e-01 | 0.411 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.904285e-01 | 0.720 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 3.330511e-01 | 0.477 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 2.946640e-01 | 0.531 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 3.714193e-01 | 0.430 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.425663e-01 | 0.354 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 2.135125e-01 | 0.671 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 2.481316e-01 | 0.605 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.196554e-01 | 0.495 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.919285e-01 | 0.308 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.199611e-01 | 0.495 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 1.384283e-01 | 0.859 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 1.478701e-01 | 0.830 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 4.572964e-01 | 0.340 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 1.821325e-01 | 0.740 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 5.256587e-01 | 0.279 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 3.510520e-01 | 0.455 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 2.090044e-01 | 0.680 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 1.890438e-01 | 0.723 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.371660e-01 | 0.625 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.858233e-01 | 0.544 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 3.814644e-01 | 0.419 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 4.272898e-01 | 0.369 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 3.137732e-01 | 0.503 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 2.866288e-01 | 0.543 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 2.595681e-01 | 0.586 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.256481e-01 | 0.371 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.123151e-01 | 0.385 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 5.131413e-01 | 0.290 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 3.580211e-01 | 0.446 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 4.572964e-01 | 0.340 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.317859e-01 | 0.635 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.290027e-01 | 0.368 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.290027e-01 | 0.368 | 0 | 0 |
| Protein folding | R-HSA-391251 | 3.763750e-01 | 0.424 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.975064e-01 | 0.704 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 2.150270e-01 | 0.668 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 4.123151e-01 | 0.385 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 2.388419e-01 | 0.622 | 0 | 0 |
| Interleukin-9 signaling | R-HSA-8985947 | 4.272898e-01 | 0.369 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 5.082323e-01 | 0.294 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 4.574464e-01 | 0.340 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.890438e-01 | 0.723 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 1.800698e-01 | 0.745 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 2.174599e-01 | 0.663 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 3.341441e-01 | 0.476 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 3.550724e-01 | 0.450 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 3.550724e-01 | 0.450 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 3.906172e-01 | 0.408 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 1.963449e-01 | 0.707 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.253605e-01 | 0.488 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 4.878546e-01 | 0.312 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.123151e-01 | 0.385 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 4.901531e-01 | 0.310 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 3.670943e-01 | 0.435 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 2.215538e-01 | 0.655 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.416795e-01 | 0.466 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.197693e-01 | 0.658 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.381537e-01 | 0.471 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.363330e-01 | 0.865 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 1.887644e-01 | 0.724 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 4.284066e-01 | 0.368 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.521005e-01 | 0.818 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 3.550724e-01 | 0.450 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 3.550724e-01 | 0.450 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 2.317859e-01 | 0.635 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 2.185778e-01 | 0.660 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 3.311050e-01 | 0.480 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 4.791501e-01 | 0.320 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.035637e-01 | 0.298 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 2.020830e-01 | 0.694 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 1.526329e-01 | 0.816 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 5.326954e-01 | 0.274 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 5.326954e-01 | 0.274 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 5.225340e-01 | 0.282 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 2.131649e-01 | 0.671 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 2.950018e-01 | 0.530 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 1.361458e-01 | 0.866 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.616305e-01 | 0.791 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 2.364948e-01 | 0.626 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.215107e-01 | 0.283 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 1.810895e-01 | 0.742 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 4.002759e-01 | 0.398 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 1.904285e-01 | 0.720 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 1.686706e-01 | 0.773 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 1.655125e-01 | 0.781 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 3.192709e-01 | 0.496 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 3.814644e-01 | 0.419 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 3.033725e-01 | 0.518 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 4.272898e-01 | 0.369 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 4.272898e-01 | 0.369 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.817210e-01 | 0.550 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 1.885037e-01 | 0.725 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 2.936202e-01 | 0.532 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 3.094478e-01 | 0.509 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 3.601801e-01 | 0.443 | 0 | 0 |
| Arachidonate production from DAG | R-HSA-426048 | 5.131413e-01 | 0.290 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.033436e-01 | 0.394 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 4.227037e-01 | 0.374 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 2.813880e-01 | 0.551 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 2.813880e-01 | 0.551 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 4.002759e-01 | 0.398 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 4.375326e-01 | 0.359 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 2.899580e-01 | 0.538 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 2.899580e-01 | 0.538 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 5.326954e-01 | 0.274 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 4.737717e-01 | 0.324 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 2.813880e-01 | 0.551 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.948533e-01 | 0.530 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 3.616695e-01 | 0.442 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.033725e-01 | 0.518 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 1.446656e-01 | 0.840 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 1.698478e-01 | 0.770 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 4.375326e-01 | 0.359 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 4.169664e-01 | 0.380 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 2.143839e-01 | 0.669 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 2.100600e-01 | 0.678 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.741484e-01 | 0.562 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.550724e-01 | 0.450 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.256481e-01 | 0.371 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 2.134839e-01 | 0.671 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 4.425663e-01 | 0.354 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 2.909515e-01 | 0.536 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 4.623962e-01 | 0.335 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.425815e-01 | 0.846 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 2.858233e-01 | 0.544 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.904285e-01 | 0.720 | 0 | 0 |
| Formation of intermediate mesoderm | R-HSA-9761174 | 2.481316e-01 | 0.605 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.174599e-01 | 0.663 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 3.192709e-01 | 0.496 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 3.814644e-01 | 0.419 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 3.077011e-01 | 0.512 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 2.459065e-01 | 0.609 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 4.599469e-01 | 0.337 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 3.291303e-01 | 0.483 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 4.933327e-01 | 0.307 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 2.816745e-01 | 0.550 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 4.919285e-01 | 0.308 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.353807e-01 | 0.868 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 3.911798e-01 | 0.408 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.652155e-01 | 0.437 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.462634e-01 | 0.461 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 2.609840e-01 | 0.583 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 1.401014e-01 | 0.854 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 3.550724e-01 | 0.450 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 1.392477e-01 | 0.856 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.615769e-01 | 0.582 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 4.599469e-01 | 0.337 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 4.599469e-01 | 0.337 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 4.928350e-01 | 0.307 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.213839e-01 | 0.283 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.677325e-01 | 0.434 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 3.196554e-01 | 0.495 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 3.022266e-01 | 0.520 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 2.077218e-01 | 0.683 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 4.299037e-01 | 0.367 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 3.033725e-01 | 0.518 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.928350e-01 | 0.307 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.299643e-01 | 0.276 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.521005e-01 | 0.818 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.890438e-01 | 0.723 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 3.276954e-01 | 0.485 | 0 | 0 |
| Mitochondrial transcription initiation | R-HSA-163282 | 3.276954e-01 | 0.485 | 0 | 0 |
| Co-stimulation by ICOS | R-HSA-9927354 | 1.800698e-01 | 0.745 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 2.135125e-01 | 0.671 | 0 | 0 |
| tRNA-derived small RNA (tsRNA or tRNA-related fragment, tRF) biogenesis | R-HSA-9708296 | 4.110465e-01 | 0.386 | 0 | 0 |
| Defective ABCC8 can cause hypo- and hyper-glycemias | R-HSA-5683177 | 4.110465e-01 | 0.386 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 4.110465e-01 | 0.386 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.920190e-01 | 0.717 | 0 | 0 |
| Ionotropic activity of kainate receptors | R-HSA-451306 | 2.835108e-01 | 0.547 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 3.192709e-01 | 0.496 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 3.192709e-01 | 0.496 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 3.814644e-01 | 0.419 | 0 | 0 |
| MET activates STAT3 | R-HSA-8875791 | 4.840682e-01 | 0.315 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.840682e-01 | 0.315 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.143839e-01 | 0.669 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 2.317859e-01 | 0.635 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 4.272898e-01 | 0.369 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 4.272898e-01 | 0.369 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 2.222223e-01 | 0.653 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 3.196554e-01 | 0.495 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 2.724953e-01 | 0.565 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 2.417745e-01 | 0.617 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.921868e-01 | 0.534 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.656505e-01 | 0.781 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 3.621717e-01 | 0.441 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 4.290027e-01 | 0.368 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 4.647107e-01 | 0.333 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.829369e-01 | 0.548 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 1.759778e-01 | 0.755 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.529649e-01 | 0.597 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 2.395095e-01 | 0.621 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 1.361458e-01 | 0.866 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.254780e-01 | 0.487 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 3.414849e-01 | 0.467 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 3.835992e-01 | 0.416 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 4.256481e-01 | 0.371 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 3.889764e-01 | 0.410 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 1.852706e-01 | 0.732 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 3.911798e-01 | 0.408 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 3.906172e-01 | 0.408 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 5.090437e-01 | 0.293 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 4.599469e-01 | 0.337 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 3.391158e-01 | 0.470 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 4.933327e-01 | 0.307 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 4.933327e-01 | 0.307 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 3.917940e-01 | 0.407 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 2.185778e-01 | 0.660 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 4.687491e-01 | 0.329 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 2.355782e-01 | 0.628 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 4.811358e-01 | 0.318 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.595814e-01 | 0.444 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 2.883497e-01 | 0.540 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.215673e-01 | 0.375 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.071005e-01 | 0.295 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 2.329428e-01 | 0.633 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.299037e-01 | 0.367 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 2.965011e-01 | 0.528 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 1.482505e-01 | 0.829 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 1.645687e-01 | 0.784 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 3.341441e-01 | 0.476 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.655125e-01 | 0.781 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 4.256481e-01 | 0.371 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 4.712638e-01 | 0.327 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.599469e-01 | 0.337 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.033436e-01 | 0.394 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 4.928350e-01 | 0.307 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 3.137732e-01 | 0.503 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 1.951732e-01 | 0.710 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 3.557554e-01 | 0.449 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.097949e-01 | 0.387 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 3.137732e-01 | 0.503 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 3.739114e-01 | 0.427 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 1.504817e-01 | 0.823 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 2.883497e-01 | 0.540 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 3.625688e-01 | 0.441 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 1.920190e-01 | 0.717 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 3.550724e-01 | 0.450 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.580211e-01 | 0.446 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 3.402008e-01 | 0.468 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 3.276954e-01 | 0.485 | 0 | 0 |
| Transcription from mitochondrial promoters | R-HSA-75944 | 4.110465e-01 | 0.386 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 2.835108e-01 | 0.547 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 2.454398e-01 | 0.610 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 1.859912e-01 | 0.731 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 1.616305e-01 | 0.791 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 2.679610e-01 | 0.572 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 3.890902e-01 | 0.410 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 4.506017e-01 | 0.346 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 5.131413e-01 | 0.290 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 4.949397e-01 | 0.305 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 3.906172e-01 | 0.408 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.571752e-01 | 0.804 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 2.633280e-01 | 0.580 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.454398e-01 | 0.610 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.840682e-01 | 0.315 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 5.216621e-01 | 0.283 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 4.110465e-01 | 0.386 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.741484e-01 | 0.562 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 3.814644e-01 | 0.419 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 2.866288e-01 | 0.543 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 3.056113e-01 | 0.515 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.812815e-01 | 0.551 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 5.131413e-01 | 0.290 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 4.113557e-01 | 0.386 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.625688e-01 | 0.441 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 4.712638e-01 | 0.327 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.433224e-01 | 0.844 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.712638e-01 | 0.327 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 4.584089e-01 | 0.339 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 5.131413e-01 | 0.290 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 2.899580e-01 | 0.538 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 4.712638e-01 | 0.327 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 2.780258e-01 | 0.556 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 2.524307e-01 | 0.598 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 2.633280e-01 | 0.580 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 5.343570e-01 | 0.272 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 5.343570e-01 | 0.272 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 5.343570e-01 | 0.272 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.343570e-01 | 0.272 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 5.343570e-01 | 0.272 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 5.384864e-01 | 0.269 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 5.384864e-01 | 0.269 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 5.388989e-01 | 0.268 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 5.388989e-01 | 0.268 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 5.397692e-01 | 0.268 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 5.413316e-01 | 0.267 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 5.413316e-01 | 0.267 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 5.413643e-01 | 0.267 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 5.444705e-01 | 0.264 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.444705e-01 | 0.264 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.472982e-01 | 0.262 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 5.479961e-01 | 0.261 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 5.480400e-01 | 0.261 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 5.480400e-01 | 0.261 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 5.480400e-01 | 0.261 | 0 | 0 |
| ATP sensitive Potassium channels | R-HSA-1296025 | 5.480400e-01 | 0.261 | 0 | 0 |
| FBXW7 Mutants and NOTCH1 in Cancer | R-HSA-2644605 | 5.480400e-01 | 0.261 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 5.480400e-01 | 0.261 | 0 | 0 |
| Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling | R-HSA-2644607 | 5.480400e-01 | 0.261 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 5.480400e-01 | 0.261 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 5.480400e-01 | 0.261 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 5.480400e-01 | 0.261 | 0 | 0 |
| MDK and PTN in ALK signaling | R-HSA-9851151 | 5.480400e-01 | 0.261 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 5.480400e-01 | 0.261 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 5.480400e-01 | 0.261 | 0 | 0 |
| Regulation of HMOX1 expression and activity | R-HSA-9707587 | 5.480400e-01 | 0.261 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 5.480400e-01 | 0.261 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.486977e-01 | 0.261 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 5.488175e-01 | 0.261 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 5.525897e-01 | 0.258 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 5.527662e-01 | 0.257 | 0 | 0 |
| FGFR2b ligand binding and activation | R-HSA-190377 | 5.527662e-01 | 0.257 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 5.527662e-01 | 0.257 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 5.527662e-01 | 0.257 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 5.527662e-01 | 0.257 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 5.527662e-01 | 0.257 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 5.527662e-01 | 0.257 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 5.527662e-01 | 0.257 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 5.527662e-01 | 0.257 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 5.527662e-01 | 0.257 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 5.568095e-01 | 0.254 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 5.568095e-01 | 0.254 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 5.568095e-01 | 0.254 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.568095e-01 | 0.254 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 5.568095e-01 | 0.254 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 5.568095e-01 | 0.254 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.568095e-01 | 0.254 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 5.573900e-01 | 0.254 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 5.608384e-01 | 0.251 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 5.608384e-01 | 0.251 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 5.608384e-01 | 0.251 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 5.618130e-01 | 0.250 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 5.618130e-01 | 0.250 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.661301e-01 | 0.247 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 5.721072e-01 | 0.243 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 5.724074e-01 | 0.242 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 5.738405e-01 | 0.241 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 5.788735e-01 | 0.237 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 5.788735e-01 | 0.237 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 5.788735e-01 | 0.237 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.820624e-01 | 0.235 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.820624e-01 | 0.235 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 5.864779e-01 | 0.232 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.864779e-01 | 0.232 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 5.864779e-01 | 0.232 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 5.865741e-01 | 0.232 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 5.866977e-01 | 0.232 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 5.866977e-01 | 0.232 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 5.866977e-01 | 0.232 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 5.875419e-01 | 0.231 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.881533e-01 | 0.231 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.892198e-01 | 0.230 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 5.892198e-01 | 0.230 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.892198e-01 | 0.230 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 5.900533e-01 | 0.229 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 5.900533e-01 | 0.229 | 0 | 0 |
| Presynaptic nicotinic acetylcholine receptors | R-HSA-622323 | 5.900533e-01 | 0.229 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 5.900533e-01 | 0.229 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 5.900533e-01 | 0.229 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 5.900533e-01 | 0.229 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 5.900533e-01 | 0.229 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 5.900533e-01 | 0.229 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 5.900533e-01 | 0.229 | 0 | 0 |
| Signaling by activated point mutants of FGFR1 | R-HSA-1839122 | 5.900533e-01 | 0.229 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 5.900533e-01 | 0.229 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 5.933782e-01 | 0.227 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 5.937672e-01 | 0.226 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 5.944065e-01 | 0.226 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 5.951478e-01 | 0.225 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.956286e-01 | 0.225 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.002218e-01 | 0.222 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 6.025190e-01 | 0.220 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 6.040829e-01 | 0.219 | 0 | 0 |
| NFE2L2 regulating TCA cycle genes | R-HSA-9818025 | 6.040829e-01 | 0.219 | 0 | 0 |
| IRS activation | R-HSA-74713 | 6.040829e-01 | 0.219 | 0 | 0 |
| Defective CYP17A1 causes AH5 | R-HSA-5579028 | 6.040829e-01 | 0.219 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 6.040829e-01 | 0.219 | 0 | 0 |
| PTK6 Down-Regulation | R-HSA-8849472 | 6.040829e-01 | 0.219 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 6.040829e-01 | 0.219 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 6.040829e-01 | 0.219 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 6.040829e-01 | 0.219 | 0 | 0 |
| Co-inhibition by BTLA | R-HSA-9927353 | 6.040829e-01 | 0.219 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 6.040829e-01 | 0.219 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 6.040829e-01 | 0.219 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.079034e-01 | 0.216 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 6.094022e-01 | 0.215 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 6.096661e-01 | 0.215 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 6.096661e-01 | 0.215 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 6.096661e-01 | 0.215 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 6.098833e-01 | 0.215 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.112222e-01 | 0.214 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.112222e-01 | 0.214 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 6.112222e-01 | 0.214 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.113036e-01 | 0.214 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 6.134863e-01 | 0.212 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 6.150462e-01 | 0.211 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 6.152610e-01 | 0.211 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 6.152610e-01 | 0.211 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.152610e-01 | 0.211 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 6.152610e-01 | 0.211 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 6.152610e-01 | 0.211 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.152610e-01 | 0.211 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 6.249730e-01 | 0.204 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 6.249730e-01 | 0.204 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 6.249730e-01 | 0.204 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 6.249730e-01 | 0.204 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 6.249730e-01 | 0.204 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 6.249730e-01 | 0.204 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 6.249730e-01 | 0.204 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 6.249730e-01 | 0.204 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 6.249730e-01 | 0.204 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 6.253360e-01 | 0.204 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 6.280871e-01 | 0.202 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 6.287472e-01 | 0.202 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.290239e-01 | 0.201 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.290239e-01 | 0.201 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.290239e-01 | 0.201 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 6.310863e-01 | 0.200 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.318013e-01 | 0.199 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 6.350301e-01 | 0.197 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 6.350301e-01 | 0.197 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 6.350301e-01 | 0.197 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.409137e-01 | 0.193 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.424591e-01 | 0.192 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 6.424591e-01 | 0.192 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 6.424591e-01 | 0.192 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.445043e-01 | 0.191 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 6.480598e-01 | 0.188 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 6.480598e-01 | 0.188 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 6.480598e-01 | 0.188 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 6.480598e-01 | 0.188 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 6.531795e-01 | 0.185 | 0 | 0 |
| Plus-strand DNA synthesis | R-HSA-164525 | 6.531795e-01 | 0.185 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 6.531795e-01 | 0.185 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 6.531795e-01 | 0.185 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 6.531795e-01 | 0.185 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 6.531795e-01 | 0.185 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 6.531795e-01 | 0.185 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 6.531795e-01 | 0.185 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 6.531795e-01 | 0.185 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 6.531795e-01 | 0.185 | 0 | 0 |
| Defective CSF2RB causes SMDP5 | R-HSA-5688849 | 6.531795e-01 | 0.185 | 0 | 0 |
| Phase 1 - inactivation of fast Na+ channels | R-HSA-5576894 | 6.531795e-01 | 0.185 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 6.531795e-01 | 0.185 | 0 | 0 |
| Defective CSF2RA causes SMDP4 | R-HSA-5688890 | 6.531795e-01 | 0.185 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 6.531795e-01 | 0.185 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 6.531795e-01 | 0.185 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 6.531795e-01 | 0.185 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 6.531795e-01 | 0.185 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 6.531795e-01 | 0.185 | 0 | 0 |
| Formation of the Editosome | R-HSA-75094 | 6.531795e-01 | 0.185 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 6.531795e-01 | 0.185 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 6.531795e-01 | 0.185 | 0 | 0 |
| Sodium-coupled phosphate cotransporters | R-HSA-427652 | 6.531795e-01 | 0.185 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 6.531795e-01 | 0.185 | 0 | 0 |
| Release of apoptotic factors from the mitochondria | R-HSA-111457 | 6.531795e-01 | 0.185 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 6.531795e-01 | 0.185 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 6.531795e-01 | 0.185 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 6.531795e-01 | 0.185 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 6.531795e-01 | 0.185 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 6.531795e-01 | 0.185 | 0 | 0 |
| Acetylcholine binding and downstream events | R-HSA-181431 | 6.575391e-01 | 0.182 | 0 | 0 |
| Postsynaptic nicotinic acetylcholine receptors | R-HSA-622327 | 6.575391e-01 | 0.182 | 0 | 0 |
| FGFR2c ligand binding and activation | R-HSA-190375 | 6.575391e-01 | 0.182 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 6.575391e-01 | 0.182 | 0 | 0 |
| FGFR1c ligand binding and activation | R-HSA-190373 | 6.575391e-01 | 0.182 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 6.575391e-01 | 0.182 | 0 | 0 |
| FGFR4 ligand binding and activation | R-HSA-190322 | 6.575391e-01 | 0.182 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.575391e-01 | 0.182 | 0 | 0 |
| Signaling by activated point mutants of FGFR3 | R-HSA-1839130 | 6.575391e-01 | 0.182 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 6.575391e-01 | 0.182 | 0 | 0 |
| FGFR3 mutant receptor activation | R-HSA-2033514 | 6.575391e-01 | 0.182 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 6.575391e-01 | 0.182 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 6.575391e-01 | 0.182 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 6.578719e-01 | 0.182 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 6.578719e-01 | 0.182 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.664895e-01 | 0.176 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 6.682708e-01 | 0.175 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.682708e-01 | 0.175 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.682708e-01 | 0.175 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.682708e-01 | 0.175 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 6.714671e-01 | 0.173 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.717084e-01 | 0.173 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 6.717084e-01 | 0.173 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 6.717084e-01 | 0.173 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 6.717084e-01 | 0.173 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 6.717084e-01 | 0.173 | 0 | 0 |
| RAB geranylgeranylation | R-HSA-8873719 | 6.764604e-01 | 0.170 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 6.797281e-01 | 0.168 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 6.797281e-01 | 0.168 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 6.836017e-01 | 0.165 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.847972e-01 | 0.164 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 6.877983e-01 | 0.163 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 6.877983e-01 | 0.163 | 0 | 0 |
| FGFR3c ligand binding and activation | R-HSA-190372 | 6.877983e-01 | 0.163 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 6.877983e-01 | 0.163 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 6.877983e-01 | 0.163 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 6.877983e-01 | 0.163 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 6.877983e-01 | 0.163 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 6.925977e-01 | 0.160 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 6.926913e-01 | 0.159 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 6.926913e-01 | 0.159 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.926913e-01 | 0.159 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 6.926913e-01 | 0.159 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 6.939283e-01 | 0.159 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 6.958685e-01 | 0.157 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 6.958685e-01 | 0.157 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 6.961223e-01 | 0.157 | 0 | 0 |
| Uncoating of the HIV Virion | R-HSA-162585 | 6.961901e-01 | 0.157 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.961901e-01 | 0.157 | 0 | 0 |
| Hydrolysis of LPE | R-HSA-1483152 | 6.961901e-01 | 0.157 | 0 | 0 |
| MET Receptor Activation | R-HSA-6806942 | 6.961901e-01 | 0.157 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 6.961901e-01 | 0.157 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.961901e-01 | 0.157 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.961901e-01 | 0.157 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 6.961901e-01 | 0.157 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.961901e-01 | 0.157 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.961901e-01 | 0.157 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 7.014713e-01 | 0.154 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 7.053613e-01 | 0.152 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 7.065900e-01 | 0.151 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 7.149427e-01 | 0.146 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 7.157295e-01 | 0.145 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 7.157295e-01 | 0.145 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 7.157295e-01 | 0.145 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 7.158218e-01 | 0.145 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 7.158218e-01 | 0.145 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 7.158218e-01 | 0.145 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 7.158218e-01 | 0.145 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 7.158218e-01 | 0.145 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 7.158218e-01 | 0.145 | 0 | 0 |
| FGFR3 ligand binding and activation | R-HSA-190239 | 7.158218e-01 | 0.145 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 7.158218e-01 | 0.145 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 7.158218e-01 | 0.145 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 7.158218e-01 | 0.145 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 7.158218e-01 | 0.145 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.165879e-01 | 0.145 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.165879e-01 | 0.145 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.180043e-01 | 0.144 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 7.181882e-01 | 0.144 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 7.204504e-01 | 0.142 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 7.204504e-01 | 0.142 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 7.204504e-01 | 0.142 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.244771e-01 | 0.140 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 7.268647e-01 | 0.139 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 7.268647e-01 | 0.139 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 7.338691e-01 | 0.134 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 7.338691e-01 | 0.134 | 0 | 0 |
| DAG1 core M1 glycosylations | R-HSA-8932506 | 7.338691e-01 | 0.134 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to gluconeogenesis | R-HSA-9632974 | 7.338691e-01 | 0.134 | 0 | 0 |
| FGFR3b ligand binding and activation | R-HSA-190371 | 7.338691e-01 | 0.134 | 0 | 0 |
| mRNA Editing: C to U Conversion | R-HSA-72200 | 7.338691e-01 | 0.134 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 7.338691e-01 | 0.134 | 0 | 0 |
| Cysteine formation from homocysteine | R-HSA-1614603 | 7.338691e-01 | 0.134 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 7.338691e-01 | 0.134 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 7.338691e-01 | 0.134 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 7.338691e-01 | 0.134 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 7.338691e-01 | 0.134 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 7.338691e-01 | 0.134 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 7.338691e-01 | 0.134 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 7.338691e-01 | 0.134 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 7.338921e-01 | 0.134 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 7.374061e-01 | 0.132 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 7.374061e-01 | 0.132 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 7.374061e-01 | 0.132 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 7.374061e-01 | 0.132 | 0 | 0 |
| Interleukin-20 family signaling | R-HSA-8854691 | 7.374061e-01 | 0.132 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 7.393195e-01 | 0.131 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 7.410832e-01 | 0.130 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 7.410832e-01 | 0.130 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.416988e-01 | 0.130 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 7.416988e-01 | 0.130 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 7.416988e-01 | 0.130 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.416988e-01 | 0.130 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 7.416988e-01 | 0.130 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 7.416988e-01 | 0.130 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 7.436870e-01 | 0.129 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 7.436870e-01 | 0.129 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 7.436870e-01 | 0.129 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 7.443873e-01 | 0.128 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.540085e-01 | 0.123 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.540085e-01 | 0.123 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.540085e-01 | 0.123 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 7.540762e-01 | 0.123 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 7.552779e-01 | 0.122 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 7.572068e-01 | 0.121 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 7.572068e-01 | 0.121 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 7.572068e-01 | 0.121 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 7.577511e-01 | 0.120 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 7.577511e-01 | 0.120 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 7.577511e-01 | 0.120 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 7.581835e-01 | 0.120 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 7.597323e-01 | 0.119 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 7.655304e-01 | 0.116 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 7.655304e-01 | 0.116 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 7.655304e-01 | 0.116 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 7.655304e-01 | 0.116 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 7.655304e-01 | 0.116 | 0 | 0 |
| Galactose catabolism | R-HSA-70370 | 7.655304e-01 | 0.116 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 7.655304e-01 | 0.116 | 0 | 0 |
| Reverse Transcription of HIV RNA | R-HSA-162589 | 7.668770e-01 | 0.115 | 0 | 0 |
| Minus-strand DNA synthesis | R-HSA-164516 | 7.668770e-01 | 0.115 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.668770e-01 | 0.115 | 0 | 0 |
| RSK activation | R-HSA-444257 | 7.668770e-01 | 0.115 | 0 | 0 |
| DAG1 core M2 glycosylations | R-HSA-8932504 | 7.668770e-01 | 0.115 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 7.668770e-01 | 0.115 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.668770e-01 | 0.115 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.668770e-01 | 0.115 | 0 | 0 |
| Highly calcium permeable nicotinic acetylcholine receptors | R-HSA-629597 | 7.668770e-01 | 0.115 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.668770e-01 | 0.115 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 7.668770e-01 | 0.115 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.668770e-01 | 0.115 | 0 | 0 |
| Fructose biosynthesis | R-HSA-5652227 | 7.668770e-01 | 0.115 | 0 | 0 |
| Nucleotide salvage defects | R-HSA-9734207 | 7.668770e-01 | 0.115 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 7.668770e-01 | 0.115 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 7.668770e-01 | 0.115 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 7.668770e-01 | 0.115 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 7.714312e-01 | 0.113 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.718389e-01 | 0.112 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 7.733116e-01 | 0.112 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 7.735917e-01 | 0.111 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 7.741289e-01 | 0.111 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 7.741289e-01 | 0.111 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.750092e-01 | 0.111 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.750318e-01 | 0.111 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 7.750318e-01 | 0.111 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 7.768023e-01 | 0.110 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 7.771883e-01 | 0.109 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 7.776933e-01 | 0.109 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 7.786423e-01 | 0.109 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 7.786423e-01 | 0.109 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.788691e-01 | 0.109 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.855548e-01 | 0.105 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 7.862127e-01 | 0.104 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 7.874259e-01 | 0.104 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 7.874259e-01 | 0.104 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 7.874259e-01 | 0.104 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 7.893776e-01 | 0.103 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 7.901071e-01 | 0.102 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.901071e-01 | 0.102 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 7.901071e-01 | 0.102 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.910232e-01 | 0.102 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 7.936054e-01 | 0.100 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 7.946035e-01 | 0.100 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 7.957926e-01 | 0.099 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.957926e-01 | 0.099 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.957926e-01 | 0.099 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.957926e-01 | 0.099 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 7.957926e-01 | 0.099 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.957926e-01 | 0.099 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 7.957926e-01 | 0.099 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.957926e-01 | 0.099 | 0 | 0 |
| Degradation of GABA | R-HSA-916853 | 7.957926e-01 | 0.099 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.957926e-01 | 0.099 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.957926e-01 | 0.099 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 7.957926e-01 | 0.099 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.957926e-01 | 0.099 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.957926e-01 | 0.099 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.957926e-01 | 0.099 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.957926e-01 | 0.099 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 7.957926e-01 | 0.099 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.957926e-01 | 0.099 | 0 | 0 |
| Butyrophilin (BTN) family interactions | R-HSA-8851680 | 7.957926e-01 | 0.099 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 7.998303e-01 | 0.097 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 8.008075e-01 | 0.096 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.037322e-01 | 0.095 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 8.037322e-01 | 0.095 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 8.044257e-01 | 0.095 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 8.054920e-01 | 0.094 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 8.070593e-01 | 0.093 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 8.074989e-01 | 0.093 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.074989e-01 | 0.093 | 0 | 0 |
| Activated point mutants of FGFR2 | R-HSA-2033519 | 8.074989e-01 | 0.093 | 0 | 0 |
| FGFR1 ligand binding and activation | R-HSA-190242 | 8.074989e-01 | 0.093 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 8.074989e-01 | 0.093 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 8.074989e-01 | 0.093 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 8.074989e-01 | 0.093 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 8.074989e-01 | 0.093 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 8.087079e-01 | 0.092 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 8.112031e-01 | 0.091 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 8.112031e-01 | 0.091 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 8.158322e-01 | 0.088 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 8.158322e-01 | 0.088 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 8.163631e-01 | 0.088 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 8.163631e-01 | 0.088 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 8.186285e-01 | 0.087 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.193344e-01 | 0.087 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 8.211231e-01 | 0.086 | 0 | 0 |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | R-HSA-629594 | 8.211231e-01 | 0.086 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 8.211231e-01 | 0.086 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 8.211231e-01 | 0.086 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 8.211231e-01 | 0.086 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 8.211231e-01 | 0.086 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 8.211231e-01 | 0.086 | 0 | 0 |
| TET1,2,3 and TDG demethylate DNA | R-HSA-5221030 | 8.211231e-01 | 0.086 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 8.211231e-01 | 0.086 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 8.211231e-01 | 0.086 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 8.211231e-01 | 0.086 | 0 | 0 |
| CASP4 inflammasome assembly | R-HSA-9948001 | 8.211231e-01 | 0.086 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 8.211231e-01 | 0.086 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 8.211231e-01 | 0.086 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 8.211231e-01 | 0.086 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 8.211231e-01 | 0.086 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 8.211231e-01 | 0.086 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 8.211231e-01 | 0.086 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 8.211231e-01 | 0.086 | 0 | 0 |
| Serotonin receptors | R-HSA-390666 | 8.211231e-01 | 0.086 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.221726e-01 | 0.085 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 8.255975e-01 | 0.083 | 0 | 0 |
| Pre-NOTCH Processing in Golgi | R-HSA-1912420 | 8.258646e-01 | 0.083 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 8.258646e-01 | 0.083 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 8.258646e-01 | 0.083 | 0 | 0 |
| Crosslinking of collagen fibrils | R-HSA-2243919 | 8.258646e-01 | 0.083 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.258646e-01 | 0.083 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 8.266527e-01 | 0.083 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 8.266527e-01 | 0.083 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 8.266527e-01 | 0.083 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 8.266527e-01 | 0.083 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 8.266527e-01 | 0.083 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 8.273364e-01 | 0.082 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 8.273364e-01 | 0.082 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 8.287127e-01 | 0.082 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 8.296057e-01 | 0.081 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.326420e-01 | 0.080 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 8.363983e-01 | 0.078 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 8.382596e-01 | 0.077 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 8.382596e-01 | 0.077 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 8.397390e-01 | 0.076 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.403782e-01 | 0.076 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 8.403782e-01 | 0.076 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.410062e-01 | 0.075 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.413058e-01 | 0.075 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.415795e-01 | 0.075 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.426375e-01 | 0.074 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 8.426375e-01 | 0.074 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 8.426375e-01 | 0.074 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 8.426375e-01 | 0.074 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.426375e-01 | 0.074 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 8.426375e-01 | 0.074 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 8.426375e-01 | 0.074 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.426375e-01 | 0.074 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 8.433128e-01 | 0.074 | 0 | 0 |
| DAG1 core M3 glycosylations | R-HSA-8932505 | 8.433128e-01 | 0.074 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 8.433128e-01 | 0.074 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 8.433128e-01 | 0.074 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 8.433128e-01 | 0.074 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 8.433128e-01 | 0.074 | 0 | 0 |
| Chylomicron assembly | R-HSA-8963888 | 8.433128e-01 | 0.074 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 8.433128e-01 | 0.074 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.437675e-01 | 0.074 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.451215e-01 | 0.073 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 8.451215e-01 | 0.073 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 8.476277e-01 | 0.072 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 8.486179e-01 | 0.071 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 8.486179e-01 | 0.071 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 8.543189e-01 | 0.068 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 8.543189e-01 | 0.068 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 8.543189e-01 | 0.068 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 8.564308e-01 | 0.067 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 8.568066e-01 | 0.067 | 0 | 0 |
| FGFR2 ligand binding and activation | R-HSA-190241 | 8.579301e-01 | 0.067 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 8.579301e-01 | 0.067 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 8.579301e-01 | 0.067 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 8.579301e-01 | 0.067 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 8.579301e-01 | 0.067 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 8.579301e-01 | 0.067 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.617480e-01 | 0.065 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 8.627511e-01 | 0.064 | 0 | 0 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 8.627511e-01 | 0.064 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 8.627511e-01 | 0.064 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 8.627511e-01 | 0.064 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.627511e-01 | 0.064 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.628832e-01 | 0.064 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 8.666465e-01 | 0.062 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 8.677082e-01 | 0.062 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 8.677318e-01 | 0.062 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.677318e-01 | 0.062 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.695323e-01 | 0.061 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 8.715000e-01 | 0.060 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 8.718515e-01 | 0.060 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 8.718515e-01 | 0.060 | 0 | 0 |
| Glutathione synthesis and recycling | R-HSA-174403 | 8.718515e-01 | 0.060 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 8.737534e-01 | 0.059 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 8.779323e-01 | 0.057 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 8.779323e-01 | 0.057 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 8.780448e-01 | 0.056 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 8.780448e-01 | 0.056 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.797788e-01 | 0.056 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 8.797788e-01 | 0.056 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.797788e-01 | 0.056 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.797788e-01 | 0.056 | 0 | 0 |
| Proline catabolism | R-HSA-70688 | 8.797788e-01 | 0.056 | 0 | 0 |
| Diseases associated with surfactant metabolism | R-HSA-5687613 | 8.797788e-01 | 0.056 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.797788e-01 | 0.056 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.797788e-01 | 0.056 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.797788e-01 | 0.056 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 8.797788e-01 | 0.056 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 8.797788e-01 | 0.056 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 8.797788e-01 | 0.056 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 8.819073e-01 | 0.055 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 8.819073e-01 | 0.055 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 8.845065e-01 | 0.053 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 8.845065e-01 | 0.053 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 8.845065e-01 | 0.053 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 8.845065e-01 | 0.053 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.845065e-01 | 0.053 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 8.845065e-01 | 0.053 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.864633e-01 | 0.052 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 8.868773e-01 | 0.052 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 8.874435e-01 | 0.052 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 8.874435e-01 | 0.052 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 8.885687e-01 | 0.051 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.932252e-01 | 0.049 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 8.944691e-01 | 0.048 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 8.946949e-01 | 0.048 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 8.946949e-01 | 0.048 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.946949e-01 | 0.048 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.946949e-01 | 0.048 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.946949e-01 | 0.048 | 0 | 0 |
| Diseases of nucleotide metabolism | R-HSA-9735804 | 8.946949e-01 | 0.048 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.946949e-01 | 0.048 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 8.946949e-01 | 0.048 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.946949e-01 | 0.048 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 8.959949e-01 | 0.048 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 8.959949e-01 | 0.048 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.959949e-01 | 0.048 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 8.965849e-01 | 0.047 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 8.966205e-01 | 0.047 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 8.973218e-01 | 0.047 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 8.982721e-01 | 0.047 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 8.984531e-01 | 0.047 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 8.984531e-01 | 0.047 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.998987e-01 | 0.046 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.027987e-01 | 0.044 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.045384e-01 | 0.044 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 9.048683e-01 | 0.043 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.048683e-01 | 0.043 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 9.054356e-01 | 0.043 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.064114e-01 | 0.043 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 9.064114e-01 | 0.043 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.064114e-01 | 0.043 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.072074e-01 | 0.042 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.072074e-01 | 0.042 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.072074e-01 | 0.042 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.072074e-01 | 0.042 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.072074e-01 | 0.042 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.072074e-01 | 0.042 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 9.077611e-01 | 0.042 | 0 | 0 |
| Synthesis of IPs in the nucleus | R-HSA-1855191 | 9.077611e-01 | 0.042 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 9.077611e-01 | 0.042 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 9.077611e-01 | 0.042 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 9.077611e-01 | 0.042 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 9.077611e-01 | 0.042 | 0 | 0 |
| Non-canonical inflammasome activation | R-HSA-9686114 | 9.077611e-01 | 0.042 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.077611e-01 | 0.042 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 9.077611e-01 | 0.042 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 9.077611e-01 | 0.042 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 9.077611e-01 | 0.042 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 9.077611e-01 | 0.042 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 9.087759e-01 | 0.042 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.096386e-01 | 0.041 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.096922e-01 | 0.041 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 9.096922e-01 | 0.041 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.121911e-01 | 0.040 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.158451e-01 | 0.038 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 9.158451e-01 | 0.038 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.158451e-01 | 0.038 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.158451e-01 | 0.038 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.158451e-01 | 0.038 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 9.158451e-01 | 0.038 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 9.158451e-01 | 0.038 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.170447e-01 | 0.038 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.176052e-01 | 0.037 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 9.185280e-01 | 0.037 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 9.192067e-01 | 0.037 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 9.192067e-01 | 0.037 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 9.192067e-01 | 0.037 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 9.192067e-01 | 0.037 | 0 | 0 |
| Protein lipoylation | R-HSA-9857492 | 9.192067e-01 | 0.037 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 9.192067e-01 | 0.037 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 9.192067e-01 | 0.037 | 0 | 0 |
| Protein repair | R-HSA-5676934 | 9.192067e-01 | 0.037 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 9.192067e-01 | 0.037 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 9.192067e-01 | 0.037 | 0 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 9.192067e-01 | 0.037 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.192922e-01 | 0.037 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 9.192922e-01 | 0.037 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 9.192922e-01 | 0.037 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.229746e-01 | 0.035 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.229746e-01 | 0.035 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.229746e-01 | 0.035 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.243793e-01 | 0.034 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.243793e-01 | 0.034 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.251208e-01 | 0.034 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.258742e-01 | 0.033 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.258742e-01 | 0.033 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.264145e-01 | 0.033 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.264145e-01 | 0.033 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.291848e-01 | 0.032 | 0 | 0 |
| Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE) | R-HSA-2142816 | 9.292326e-01 | 0.032 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 9.292326e-01 | 0.032 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 9.292326e-01 | 0.032 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 9.292326e-01 | 0.032 | 0 | 0 |
| Synthesis of wybutosine at G37 of tRNA(Phe) | R-HSA-6782861 | 9.292326e-01 | 0.032 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 9.293293e-01 | 0.032 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 9.294913e-01 | 0.032 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.299019e-01 | 0.032 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.299019e-01 | 0.032 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.299019e-01 | 0.032 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.299019e-01 | 0.032 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.318476e-01 | 0.031 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.319686e-01 | 0.031 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.320921e-01 | 0.031 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.320921e-01 | 0.031 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 9.320921e-01 | 0.031 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 9.320921e-01 | 0.031 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.362518e-01 | 0.029 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.376057e-01 | 0.028 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 9.380149e-01 | 0.028 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 9.380149e-01 | 0.028 | 0 | 0 |
| Glycine degradation | R-HSA-6783984 | 9.380149e-01 | 0.028 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 9.380149e-01 | 0.028 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 9.380149e-01 | 0.028 | 0 | 0 |
| tRNA modification in the mitochondrion | R-HSA-6787450 | 9.380149e-01 | 0.028 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 9.390558e-01 | 0.027 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.390558e-01 | 0.027 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 9.395743e-01 | 0.027 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.407291e-01 | 0.027 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.407291e-01 | 0.027 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 9.420663e-01 | 0.026 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 9.432293e-01 | 0.025 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 9.453375e-01 | 0.024 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.453375e-01 | 0.024 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 9.453375e-01 | 0.024 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.453375e-01 | 0.024 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.453528e-01 | 0.024 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.473855e-01 | 0.023 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 9.473855e-01 | 0.023 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 9.473855e-01 | 0.023 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 9.473855e-01 | 0.023 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.496568e-01 | 0.022 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.509992e-01 | 0.022 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 9.509992e-01 | 0.022 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.520596e-01 | 0.021 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.522471e-01 | 0.021 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.522471e-01 | 0.021 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.522471e-01 | 0.021 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.522471e-01 | 0.021 | 0 | 0 |
| Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET) | R-HSA-2142670 | 9.524462e-01 | 0.021 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.524462e-01 | 0.021 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.524462e-01 | 0.021 | 0 | 0 |
| Vitamin D (calciferol) metabolism | R-HSA-196791 | 9.524462e-01 | 0.021 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 9.524462e-01 | 0.021 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.556759e-01 | 0.020 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.561472e-01 | 0.019 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.561472e-01 | 0.019 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.566863e-01 | 0.019 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.566863e-01 | 0.019 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.566863e-01 | 0.019 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 9.583487e-01 | 0.018 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 9.583487e-01 | 0.018 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 9.583487e-01 | 0.018 | 0 | 0 |
| HDL remodeling | R-HSA-8964058 | 9.583487e-01 | 0.018 | 0 | 0 |
| Strand-asynchronous mitochondrial DNA replication | R-HSA-9913635 | 9.583487e-01 | 0.018 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.599108e-01 | 0.018 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.633733e-01 | 0.016 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 9.635189e-01 | 0.016 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 9.635189e-01 | 0.016 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 9.635189e-01 | 0.016 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.635189e-01 | 0.016 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.635189e-01 | 0.016 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.639267e-01 | 0.016 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.642072e-01 | 0.016 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.644307e-01 | 0.016 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 9.649252e-01 | 0.016 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 9.671939e-01 | 0.014 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.677917e-01 | 0.014 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.680098e-01 | 0.014 | 0 | 0 |
| Matriglycan biosynthesis on DAG1 | R-HSA-9939291 | 9.680475e-01 | 0.014 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 9.680475e-01 | 0.014 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 9.680475e-01 | 0.014 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.685203e-01 | 0.014 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.704907e-01 | 0.013 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.708527e-01 | 0.013 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.710856e-01 | 0.013 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.718501e-01 | 0.012 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.718501e-01 | 0.012 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.720142e-01 | 0.012 | 0 | 0 |
| Androgen biosynthesis | R-HSA-193048 | 9.720142e-01 | 0.012 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 9.720142e-01 | 0.012 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.720142e-01 | 0.012 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.720142e-01 | 0.012 | 0 | 0 |
| Glucocorticoid biosynthesis | R-HSA-194002 | 9.720142e-01 | 0.012 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.721630e-01 | 0.012 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.727934e-01 | 0.012 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.746241e-01 | 0.011 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.748385e-01 | 0.011 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.751817e-01 | 0.011 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.754887e-01 | 0.011 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.754887e-01 | 0.011 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.754887e-01 | 0.011 | 0 | 0 |
| Cellular hexose transport | R-HSA-189200 | 9.754887e-01 | 0.011 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.759184e-01 | 0.011 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.760874e-01 | 0.011 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 9.761671e-01 | 0.010 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.761671e-01 | 0.010 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.768797e-01 | 0.010 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 9.775191e-01 | 0.010 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.775191e-01 | 0.010 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.783962e-01 | 0.009 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 9.785320e-01 | 0.009 | 0 | 0 |
| ABC transporters in lipid homeostasis | R-HSA-1369062 | 9.785320e-01 | 0.009 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.799221e-01 | 0.009 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.799221e-01 | 0.009 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.799221e-01 | 0.009 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.805513e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.809994e-01 | 0.008 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 9.811976e-01 | 0.008 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 9.811976e-01 | 0.008 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.811976e-01 | 0.008 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 9.811976e-01 | 0.008 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.820751e-01 | 0.008 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.821316e-01 | 0.008 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.826799e-01 | 0.008 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.826993e-01 | 0.008 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.830302e-01 | 0.007 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.835323e-01 | 0.007 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 9.835323e-01 | 0.007 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.835323e-01 | 0.007 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.835323e-01 | 0.007 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.840032e-01 | 0.007 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.840032e-01 | 0.007 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.840032e-01 | 0.007 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 9.840032e-01 | 0.007 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.841588e-01 | 0.007 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.842715e-01 | 0.007 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 9.849149e-01 | 0.007 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.849149e-01 | 0.007 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 9.855773e-01 | 0.006 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.855773e-01 | 0.006 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.855773e-01 | 0.006 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.855773e-01 | 0.006 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 9.855773e-01 | 0.006 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 9.857128e-01 | 0.006 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.857290e-01 | 0.006 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.857290e-01 | 0.006 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.872730e-01 | 0.006 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.873684e-01 | 0.006 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.873684e-01 | 0.006 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.883933e-01 | 0.005 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.886537e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.886537e-01 | 0.005 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 9.887885e-01 | 0.005 | 0 | 0 |
| Prednisone ADME | R-HSA-9757110 | 9.889372e-01 | 0.005 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.889372e-01 | 0.005 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.892187e-01 | 0.005 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.892894e-01 | 0.005 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.894692e-01 | 0.005 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.895368e-01 | 0.005 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.898879e-01 | 0.004 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.898879e-01 | 0.004 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.898879e-01 | 0.004 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.903112e-01 | 0.004 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 9.903112e-01 | 0.004 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.903112e-01 | 0.004 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.908894e-01 | 0.004 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.909906e-01 | 0.004 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.912607e-01 | 0.004 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.915271e-01 | 0.004 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.918576e-01 | 0.004 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.919520e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.919520e-01 | 0.004 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.924012e-01 | 0.003 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.925687e-01 | 0.003 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.925687e-01 | 0.003 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 9.925687e-01 | 0.003 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.925687e-01 | 0.003 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.927070e-01 | 0.003 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.927391e-01 | 0.003 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.928547e-01 | 0.003 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.928547e-01 | 0.003 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.931279e-01 | 0.003 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.931279e-01 | 0.003 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.931279e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.931436e-01 | 0.003 | 0 | 0 |
| DAG1 glycosylations | R-HSA-8931838 | 9.934918e-01 | 0.003 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.934918e-01 | 0.003 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 9.938356e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.938356e-01 | 0.003 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.940299e-01 | 0.003 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.943003e-01 | 0.002 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.944597e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.944597e-01 | 0.002 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.949639e-01 | 0.002 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.949747e-01 | 0.002 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.950085e-01 | 0.002 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.950113e-01 | 0.002 | 0 | 0 |
| Glyoxylate metabolism and glycine degradation | R-HSA-389661 | 9.955205e-01 | 0.002 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.955205e-01 | 0.002 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 9.955687e-01 | 0.002 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.956286e-01 | 0.002 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.956286e-01 | 0.002 | 0 | 0 |
| RA biosynthesis pathway | R-HSA-5365859 | 9.956286e-01 | 0.002 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.956286e-01 | 0.002 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.956286e-01 | 0.002 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.957938e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.959415e-01 | 0.002 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.959898e-01 | 0.002 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.961718e-01 | 0.002 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.961718e-01 | 0.002 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.961718e-01 | 0.002 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.961718e-01 | 0.002 | 0 | 0 |
| Metabolism of ingested SeMet, Sec, MeSec into H2Se | R-HSA-2408508 | 9.961718e-01 | 0.002 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.963784e-01 | 0.002 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.965925e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.970998e-01 | 0.001 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.974289e-01 | 0.001 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.974414e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.976301e-01 | 0.001 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.977182e-01 | 0.001 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.977485e-01 | 0.001 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.977485e-01 | 0.001 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.979003e-01 | 0.001 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.979102e-01 | 0.001 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.980283e-01 | 0.001 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.981275e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.981275e-01 | 0.001 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.982734e-01 | 0.001 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.984052e-01 | 0.001 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.984880e-01 | 0.001 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.986288e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.986552e-01 | 0.001 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.986760e-01 | 0.001 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.987833e-01 | 0.001 | 0 | 0 |
| Glutathione conjugation | R-HSA-156590 | 9.987833e-01 | 0.001 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.988406e-01 | 0.001 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.988406e-01 | 0.001 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.988406e-01 | 0.001 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.989205e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.989424e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.989424e-01 | 0.000 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.989847e-01 | 0.000 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.989847e-01 | 0.000 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.991109e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.991380e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.991508e-01 | 0.000 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.992031e-01 | 0.000 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.992215e-01 | 0.000 | 0 | 0 |
| Metabolic disorders of biological oxidation enzymes | R-HSA-5579029 | 9.992292e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.993818e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.993841e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.994755e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.994755e-01 | 0.000 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.994773e-01 | 0.000 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 9.995423e-01 | 0.000 | 0 | 0 |
| Synthesis of Prostaglandins (PG) and Thromboxanes (TX) | R-HSA-2162123 | 9.995423e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.995898e-01 | 0.000 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.995992e-01 | 0.000 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.996491e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.996768e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.996768e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.996810e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.996873e-01 | 0.000 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.997107e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.997138e-01 | 0.000 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.997644e-01 | 0.000 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.997937e-01 | 0.000 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.997937e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.997952e-01 | 0.000 | 0 | 0 |
| Sialic acid metabolism | R-HSA-4085001 | 9.998615e-01 | 0.000 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.998623e-01 | 0.000 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.998623e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.998788e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.998936e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.999005e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999063e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.999186e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999210e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999210e-01 | 0.000 | 0 | 0 |
| CD22 mediated BCR regulation | R-HSA-5690714 | 9.999288e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.999288e-01 | 0.000 | 0 | 0 |
| Xenobiotics | R-HSA-211981 | 9.999288e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999370e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999374e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.999376e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.999581e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999635e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999650e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid catabolism | R-HSA-9840310 | 9.999679e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999686e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999722e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.999754e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.999785e-01 | 0.000 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.999785e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999798e-01 | 0.000 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.999835e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999846e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999878e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999889e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999892e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.999929e-01 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.999941e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999952e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.999953e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999957e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999966e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999971e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999974e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999975e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999984e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.999987e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999993e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999995e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999995e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999997e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999998e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999999e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999999e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999999e-01 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 1.000000e+00 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 1.000000e+00 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cell Cycle | R-HSA-1640170 | 1.110223e-16 | 15.955 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.110223e-16 | 15.955 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.440892e-15 | 14.353 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 1.312728e-12 | 11.882 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.290978e-11 | 10.889 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 1.254719e-11 | 10.901 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 4.971801e-11 | 10.303 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 8.747558e-11 | 10.058 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.213967e-09 | 8.916 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.270325e-09 | 8.896 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 1.445310e-09 | 8.840 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 1.984621e-09 | 8.702 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 2.313946e-09 | 8.636 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 4.329259e-09 | 8.364 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 7.125672e-09 | 8.147 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.567634e-08 | 7.590 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 1.033003e-07 | 6.986 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.282129e-07 | 6.892 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.707918e-07 | 6.768 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 3.864430e-07 | 6.413 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 4.080176e-07 | 6.389 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 4.202612e-07 | 6.376 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 4.415483e-07 | 6.355 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.036077e-07 | 6.298 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 5.552960e-07 | 6.255 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 7.878989e-07 | 6.104 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 1.089410e-06 | 5.963 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.119389e-06 | 5.951 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.811380e-06 | 5.742 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.091178e-06 | 5.388 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.143154e-06 | 5.289 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 5.455653e-06 | 5.263 | 0 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 8.548792e-06 | 5.068 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 8.543338e-06 | 5.068 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 8.806472e-06 | 5.055 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 9.453604e-06 | 5.024 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.090482e-05 | 4.962 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 1.182116e-05 | 4.927 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 1.334541e-05 | 4.875 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 1.334541e-05 | 4.875 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 1.320074e-05 | 4.879 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 1.311671e-05 | 4.882 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.450933e-05 | 4.838 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.681476e-05 | 4.774 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 1.681476e-05 | 4.774 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.663233e-05 | 4.779 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 1.731892e-05 | 4.761 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.828459e-05 | 4.738 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 2.078986e-05 | 4.682 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 2.474749e-05 | 4.606 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.521281e-05 | 4.598 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 2.789038e-05 | 4.555 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.005460e-05 | 4.522 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 3.121168e-05 | 4.506 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 3.468521e-05 | 4.460 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 4.034270e-05 | 4.394 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 4.274021e-05 | 4.369 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.296849e-05 | 4.367 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 4.213561e-05 | 4.375 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 4.550633e-05 | 4.342 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 4.701363e-05 | 4.328 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 4.937610e-05 | 4.306 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 5.102629e-05 | 4.292 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 5.579048e-05 | 4.253 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 6.418666e-05 | 4.193 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 6.443072e-05 | 4.191 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 6.492722e-05 | 4.188 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.541686e-05 | 4.184 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 6.553467e-05 | 4.184 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 7.253382e-05 | 4.139 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.338426e-05 | 4.134 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 8.470826e-05 | 4.072 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.185862e-05 | 4.037 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.510797e-05 | 4.022 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 9.510797e-05 | 4.022 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 1.178563e-04 | 3.929 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 1.125621e-04 | 3.949 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 1.179047e-04 | 3.928 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 1.451018e-04 | 3.838 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 1.427362e-04 | 3.845 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 1.427362e-04 | 3.845 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 1.427362e-04 | 3.845 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 1.427362e-04 | 3.845 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.480548e-04 | 3.830 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 1.386760e-04 | 3.858 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 1.408177e-04 | 3.851 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 1.526491e-04 | 3.816 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 1.534207e-04 | 3.814 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.605019e-04 | 3.795 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.666193e-04 | 3.778 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 1.886977e-04 | 3.724 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 1.986007e-04 | 3.702 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 1.986007e-04 | 3.702 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 2.032501e-04 | 3.692 | 0 | 0 |
| Protein folding | R-HSA-391251 | 2.348298e-04 | 3.629 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.375110e-04 | 3.624 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 2.453080e-04 | 3.610 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 2.648797e-04 | 3.577 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 2.792741e-04 | 3.554 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.968583e-04 | 3.527 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 2.837397e-04 | 3.547 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.968583e-04 | 3.527 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 2.980735e-04 | 3.526 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 3.113746e-04 | 3.507 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 4.136833e-04 | 3.383 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 4.170309e-04 | 3.380 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 4.170309e-04 | 3.380 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 4.233593e-04 | 3.373 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 4.418199e-04 | 3.355 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.784019e-04 | 3.320 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 4.612308e-04 | 3.336 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.546074e-04 | 3.342 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.555291e-04 | 3.341 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 4.866517e-04 | 3.313 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 4.909383e-04 | 3.309 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 4.909383e-04 | 3.309 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 5.485779e-04 | 3.261 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 5.515468e-04 | 3.258 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 5.977152e-04 | 3.224 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 5.977152e-04 | 3.224 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 5.562553e-04 | 3.255 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 5.863839e-04 | 3.232 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 5.881020e-04 | 3.231 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.182976e-04 | 3.209 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.182976e-04 | 3.209 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 6.699456e-04 | 3.174 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 6.893154e-04 | 3.162 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 7.372589e-04 | 3.132 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 7.372589e-04 | 3.132 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 7.285970e-04 | 3.138 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 6.808991e-04 | 3.167 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 7.556303e-04 | 3.122 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.724556e-04 | 3.112 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 7.724556e-04 | 3.112 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 7.944226e-04 | 3.100 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 8.064254e-04 | 3.093 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 8.064254e-04 | 3.093 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 8.441498e-04 | 3.074 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 8.581283e-04 | 3.066 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 8.581283e-04 | 3.066 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 9.396487e-04 | 3.027 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 9.396487e-04 | 3.027 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 8.953878e-04 | 3.048 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 9.596955e-04 | 3.018 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 9.906498e-04 | 3.004 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 1.000867e-03 | 3.000 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 1.000867e-03 | 3.000 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 1.033771e-03 | 2.986 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.039903e-03 | 2.983 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 1.137198e-03 | 2.944 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 1.137198e-03 | 2.944 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 1.143025e-03 | 2.942 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 1.165660e-03 | 2.933 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 1.213956e-03 | 2.916 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 1.389146e-03 | 2.857 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 1.326916e-03 | 2.877 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 1.425018e-03 | 2.846 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 1.519128e-03 | 2.818 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 1.535652e-03 | 2.814 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 1.548528e-03 | 2.810 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 1.579889e-03 | 2.801 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 1.582633e-03 | 2.801 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 1.903352e-03 | 2.720 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.963097e-03 | 2.707 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 2.058320e-03 | 2.686 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.062107e-03 | 2.686 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.073965e-03 | 2.683 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.078888e-03 | 2.682 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.196431e-03 | 2.658 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 2.212931e-03 | 2.655 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.322216e-03 | 2.634 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.337181e-03 | 2.631 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 2.589346e-03 | 2.587 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 2.628752e-03 | 2.580 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 2.645438e-03 | 2.578 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 2.645438e-03 | 2.578 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 2.681610e-03 | 2.572 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 2.785489e-03 | 2.555 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 2.813374e-03 | 2.551 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 3.049137e-03 | 2.516 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 3.138737e-03 | 2.503 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.139445e-03 | 2.503 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 3.301682e-03 | 2.481 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.449268e-03 | 2.462 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 3.449268e-03 | 2.462 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.449268e-03 | 2.462 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 3.705506e-03 | 2.431 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.422896e-03 | 2.466 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 3.449268e-03 | 2.462 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.492942e-03 | 2.457 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.804084e-03 | 2.420 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 3.497332e-03 | 2.456 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 3.861055e-03 | 2.413 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 4.048338e-03 | 2.393 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 4.048338e-03 | 2.393 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 4.165903e-03 | 2.380 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 4.207089e-03 | 2.376 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.220030e-03 | 2.375 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.285496e-03 | 2.368 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 4.313566e-03 | 2.365 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 4.677166e-03 | 2.330 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.828723e-03 | 2.316 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.913536e-03 | 2.309 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 4.937349e-03 | 2.307 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 5.312903e-03 | 2.275 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 5.667347e-03 | 2.247 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 5.667347e-03 | 2.247 | 0 | 0 |
| Endosomal Sorting Complex Required For Transport (ESCRT) | R-HSA-917729 | 6.071656e-03 | 2.217 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 6.178021e-03 | 2.209 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 6.789400e-03 | 2.168 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.720209e-03 | 2.173 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 6.789400e-03 | 2.168 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 6.789400e-03 | 2.168 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 7.104771e-03 | 2.148 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.476429e-03 | 2.189 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 6.776052e-03 | 2.169 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 6.789400e-03 | 2.168 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 7.241913e-03 | 2.140 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 7.315217e-03 | 2.136 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.623133e-03 | 2.118 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 7.807156e-03 | 2.108 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 7.807156e-03 | 2.108 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 7.833416e-03 | 2.106 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 7.833416e-03 | 2.106 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 7.833416e-03 | 2.106 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 8.398855e-03 | 2.076 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 8.746861e-03 | 2.058 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 9.004322e-03 | 2.046 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 9.004322e-03 | 2.046 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.016328e-03 | 2.045 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.031219e-03 | 2.044 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 9.078307e-03 | 2.042 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 9.078307e-03 | 2.042 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 9.136128e-03 | 2.039 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 9.136128e-03 | 2.039 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 9.136128e-03 | 2.039 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 9.294509e-03 | 2.032 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 9.294509e-03 | 2.032 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 9.347916e-03 | 2.029 | 1 | 0 |
| Gap junction degradation | R-HSA-190873 | 1.108340e-02 | 1.955 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 1.108340e-02 | 1.955 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 1.091320e-02 | 1.962 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 1.056697e-02 | 1.976 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.056697e-02 | 1.976 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 9.991955e-03 | 2.000 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 1.022843e-02 | 1.990 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 9.757470e-03 | 2.011 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 1.091320e-02 | 1.962 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 9.560406e-03 | 2.020 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 1.126400e-02 | 1.948 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 1.175117e-02 | 1.930 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.183332e-02 | 1.927 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 1.185733e-02 | 1.926 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 1.201148e-02 | 1.920 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 1.209888e-02 | 1.917 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 1.224397e-02 | 1.912 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 1.224397e-02 | 1.912 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.227509e-02 | 1.911 | 0 | 0 |
| Maturation of protein E | R-HSA-9683683 | 1.227509e-02 | 1.911 | 0 | 0 |
| Maturation of protein E | R-HSA-9694493 | 1.227509e-02 | 1.911 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 1.330227e-02 | 1.876 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 1.409209e-02 | 1.851 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 1.409209e-02 | 1.851 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.416179e-02 | 1.849 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 1.434453e-02 | 1.843 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.462662e-02 | 1.835 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 1.481429e-02 | 1.829 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 1.485442e-02 | 1.828 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 1.514914e-02 | 1.820 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.514914e-02 | 1.820 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 1.542537e-02 | 1.812 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 1.547045e-02 | 1.810 | 0 | 0 |
| Signaling by cytosolic PDGFRA and PDGFRB fusion proteins | R-HSA-9673766 | 1.821965e-02 | 1.739 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 1.665443e-02 | 1.778 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.665443e-02 | 1.778 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 1.670306e-02 | 1.777 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 1.800422e-02 | 1.745 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.574244e-02 | 1.803 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.583656e-02 | 1.800 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 1.807560e-02 | 1.743 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 1.798211e-02 | 1.745 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.877913e-02 | 1.726 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 1.788013e-02 | 1.748 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 1.583656e-02 | 1.800 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 1.617433e-02 | 1.791 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.806919e-02 | 1.743 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 1.578471e-02 | 1.802 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.900221e-02 | 1.721 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 1.919123e-02 | 1.717 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 1.925200e-02 | 1.716 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 1.930978e-02 | 1.714 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 1.956412e-02 | 1.709 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 1.956412e-02 | 1.709 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.956412e-02 | 1.709 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 1.956412e-02 | 1.709 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 1.956412e-02 | 1.709 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.956412e-02 | 1.709 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 2.010683e-02 | 1.697 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 2.038691e-02 | 1.691 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 2.073621e-02 | 1.683 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 2.085770e-02 | 1.681 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 2.158061e-02 | 1.666 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 2.159780e-02 | 1.666 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 2.184469e-02 | 1.661 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.226234e-02 | 1.652 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 2.277437e-02 | 1.643 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.299627e-02 | 1.638 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 2.346364e-02 | 1.630 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 2.368491e-02 | 1.626 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 2.371336e-02 | 1.625 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.433869e-02 | 1.614 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 2.433869e-02 | 1.614 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.531824e-02 | 1.597 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.531824e-02 | 1.597 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.602087e-02 | 1.585 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 2.602087e-02 | 1.585 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 2.763596e-02 | 1.559 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 2.785368e-02 | 1.555 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 3.035373e-02 | 1.518 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 2.584366e-02 | 1.588 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 2.495802e-02 | 1.603 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 2.983467e-02 | 1.525 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 3.083196e-02 | 1.511 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 3.083196e-02 | 1.511 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 2.664392e-02 | 1.574 | 1 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.035373e-02 | 1.518 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 3.035373e-02 | 1.518 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 3.017311e-02 | 1.520 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 2.495802e-02 | 1.603 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 2.691914e-02 | 1.570 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 2.687224e-02 | 1.571 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 2.637222e-02 | 1.579 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 2.870912e-02 | 1.542 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 2.495802e-02 | 1.603 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 2.672547e-02 | 1.573 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 3.121761e-02 | 1.506 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 3.121761e-02 | 1.506 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 3.229610e-02 | 1.491 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 3.294273e-02 | 1.482 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 3.294273e-02 | 1.482 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 3.294273e-02 | 1.482 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 3.294273e-02 | 1.482 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 3.294273e-02 | 1.482 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 3.294273e-02 | 1.482 | 0 | 0 |
| VLDLR internalisation and degradation | R-HSA-8866427 | 3.294273e-02 | 1.482 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 3.294273e-02 | 1.482 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 3.294273e-02 | 1.482 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.294876e-02 | 1.482 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 3.379579e-02 | 1.471 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 3.409046e-02 | 1.467 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 3.409046e-02 | 1.467 | 0 | 0 |
| Modulation by Mtb of host immune system | R-HSA-9637628 | 3.409046e-02 | 1.467 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 3.473606e-02 | 1.459 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 3.473606e-02 | 1.459 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 3.474549e-02 | 1.459 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 3.524084e-02 | 1.453 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 3.537086e-02 | 1.451 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.592181e-02 | 1.445 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 3.608620e-02 | 1.443 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 3.608620e-02 | 1.443 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 3.608620e-02 | 1.443 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.638087e-02 | 1.439 | 1 | 1 |
| FGFR2 alternative splicing | R-HSA-6803529 | 3.678292e-02 | 1.434 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 3.678292e-02 | 1.434 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 3.715892e-02 | 1.430 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 3.719601e-02 | 1.430 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 3.882780e-02 | 1.411 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.882780e-02 | 1.411 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 3.882780e-02 | 1.411 | 0 | 0 |
| Manipulation of host energy metabolism | R-HSA-9636667 | 4.344904e-02 | 1.362 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 4.267445e-02 | 1.370 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 4.267445e-02 | 1.370 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 4.442039e-02 | 1.352 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 4.442039e-02 | 1.352 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 4.091034e-02 | 1.388 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 4.312063e-02 | 1.365 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 5.095817e-02 | 1.293 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 5.095817e-02 | 1.293 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 5.095817e-02 | 1.293 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 3.953487e-02 | 1.403 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 3.953487e-02 | 1.403 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 4.323248e-02 | 1.364 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 3.982670e-02 | 1.400 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 4.034059e-02 | 1.394 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.168684e-02 | 1.380 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 5.079282e-02 | 1.294 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 3.953487e-02 | 1.403 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 3.953487e-02 | 1.403 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 4.337308e-02 | 1.363 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 5.250074e-02 | 1.280 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 5.250074e-02 | 1.280 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 4.312063e-02 | 1.365 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 4.344904e-02 | 1.362 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.296453e-02 | 1.367 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 5.216748e-02 | 1.283 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 4.033556e-02 | 1.394 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 4.156930e-02 | 1.381 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 4.432455e-02 | 1.353 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 4.442039e-02 | 1.352 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 3.953487e-02 | 1.403 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 5.216748e-02 | 1.283 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 4.442039e-02 | 1.352 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.994782e-02 | 1.301 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 4.994782e-02 | 1.301 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 3.953487e-02 | 1.403 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 3.955240e-02 | 1.403 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 4.850870e-02 | 1.314 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.255773e-02 | 1.279 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 5.255773e-02 | 1.279 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 5.275777e-02 | 1.278 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 5.304585e-02 | 1.275 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 5.309867e-02 | 1.275 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 5.309867e-02 | 1.275 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 5.309867e-02 | 1.275 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 5.330134e-02 | 1.273 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 5.330134e-02 | 1.273 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 5.330134e-02 | 1.273 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 5.330134e-02 | 1.273 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 5.330134e-02 | 1.273 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 5.401012e-02 | 1.268 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 5.401012e-02 | 1.268 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 5.418451e-02 | 1.266 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 5.444833e-02 | 1.264 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 5.582793e-02 | 1.253 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 5.585299e-02 | 1.253 | 0 | 0 |
| Translation | R-HSA-72766 | 5.588342e-02 | 1.253 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 5.603185e-02 | 1.252 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 5.631129e-02 | 1.249 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 5.631129e-02 | 1.249 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 7.198223e-02 | 1.143 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 7.198223e-02 | 1.143 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 7.198223e-02 | 1.143 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 7.198223e-02 | 1.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 7.198223e-02 | 1.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 7.198223e-02 | 1.143 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 7.198223e-02 | 1.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 7.198223e-02 | 1.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 7.198223e-02 | 1.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 7.198223e-02 | 1.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 7.198223e-02 | 1.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 7.198223e-02 | 1.143 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 7.198223e-02 | 1.143 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 5.889667e-02 | 1.230 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.889667e-02 | 1.230 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.889667e-02 | 1.230 | 0 | 0 |
| CREB phosphorylation | R-HSA-199920 | 7.757408e-02 | 1.110 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 7.757408e-02 | 1.110 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 6.973830e-02 | 1.157 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 6.973830e-02 | 1.157 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 6.973830e-02 | 1.157 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 6.973830e-02 | 1.157 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 6.973830e-02 | 1.157 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 8.465188e-02 | 1.072 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 6.006572e-02 | 1.221 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 6.006572e-02 | 1.221 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 7.126148e-02 | 1.147 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 7.126148e-02 | 1.147 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 7.126148e-02 | 1.147 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 5.961176e-02 | 1.225 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 5.961176e-02 | 1.225 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 5.961176e-02 | 1.225 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 5.961176e-02 | 1.225 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.352016e-02 | 1.078 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.352016e-02 | 1.078 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 7.938252e-02 | 1.100 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 7.938252e-02 | 1.100 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 6.536225e-02 | 1.185 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 7.414207e-02 | 1.130 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.540410e-02 | 1.069 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 7.038649e-02 | 1.153 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.038649e-02 | 1.153 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 6.382259e-02 | 1.195 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 7.688704e-02 | 1.114 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 7.562513e-02 | 1.121 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.779288e-02 | 1.109 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 5.961176e-02 | 1.225 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 6.860688e-02 | 1.164 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 6.609508e-02 | 1.180 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.352016e-02 | 1.078 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 6.103509e-02 | 1.214 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 6.314681e-02 | 1.200 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 6.536225e-02 | 1.185 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.506086e-02 | 1.070 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 6.006572e-02 | 1.221 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 5.708144e-02 | 1.244 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 5.981686e-02 | 1.223 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 7.038649e-02 | 1.153 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 7.934733e-02 | 1.100 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 5.981686e-02 | 1.223 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 5.981686e-02 | 1.223 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 6.860688e-02 | 1.164 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.022929e-02 | 1.153 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.469514e-02 | 1.127 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 6.361414e-02 | 1.196 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 7.625349e-02 | 1.118 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.388303e-02 | 1.076 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 5.724307e-02 | 1.242 | 0 | 0 |
| TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling | R-HSA-975110 | 8.352016e-02 | 1.078 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 8.540410e-02 | 1.069 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 6.023138e-02 | 1.220 | 1 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.708144e-02 | 1.244 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.141547e-02 | 1.212 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 8.465188e-02 | 1.072 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.938252e-02 | 1.100 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 7.938252e-02 | 1.100 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 6.908704e-02 | 1.161 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 7.451127e-02 | 1.128 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 7.067713e-02 | 1.151 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 5.766873e-02 | 1.239 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 7.067713e-02 | 1.151 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 7.067713e-02 | 1.151 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 6.389573e-02 | 1.195 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 6.819886e-02 | 1.166 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.908704e-02 | 1.161 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 6.536225e-02 | 1.185 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 6.860688e-02 | 1.164 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.908704e-02 | 1.161 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 7.414207e-02 | 1.130 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.860688e-02 | 1.164 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 8.201582e-02 | 1.086 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.831796e-02 | 1.165 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.544739e-02 | 1.068 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 7.938252e-02 | 1.100 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.938252e-02 | 1.100 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 7.421614e-02 | 1.130 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 5.789596e-02 | 1.237 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 8.572168e-02 | 1.067 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 8.572168e-02 | 1.067 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 8.572168e-02 | 1.067 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 8.685124e-02 | 1.061 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 8.691653e-02 | 1.061 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 8.768447e-02 | 1.057 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.988562e-02 | 1.046 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 9.048973e-02 | 1.043 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.265070e-02 | 1.033 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.281650e-02 | 1.032 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 9.281650e-02 | 1.032 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 9.305625e-02 | 1.031 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 9.367891e-02 | 1.028 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 9.367891e-02 | 1.028 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.367891e-02 | 1.028 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 9.419162e-02 | 1.026 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 9.419162e-02 | 1.026 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 9.419162e-02 | 1.026 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 9.462856e-02 | 1.024 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.462856e-02 | 1.024 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 9.462856e-02 | 1.024 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 9.462856e-02 | 1.024 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 9.578524e-02 | 1.019 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 9.578524e-02 | 1.019 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.615807e-02 | 1.017 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 9.681541e-02 | 1.014 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 9.681541e-02 | 1.014 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 9.681541e-02 | 1.014 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 9.707171e-02 | 1.013 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.751329e-02 | 1.011 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 9.804207e-02 | 1.009 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 9.848777e-02 | 1.007 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.857825e-02 | 1.006 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.009815e-01 | 0.996 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 1.010973e-01 | 0.995 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 1.023936e-01 | 0.990 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 1.028273e-01 | 0.988 | 0 | 0 |
| Deletions in the AMER1 gene destabilize the destruction complex | R-HSA-5467343 | 1.037054e-01 | 0.984 | 0 | 0 |
| Loss of Function of TP53 in Cancer | R-HSA-9723907 | 1.037054e-01 | 0.984 | 0 | 0 |
| Loss of function of TP53 in cancer due to loss of tetramerization ability | R-HSA-9723905 | 1.037054e-01 | 0.984 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 1.037054e-01 | 0.984 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 1.043979e-01 | 0.981 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.043979e-01 | 0.981 | 0 | 0 |
| CaM pathway | R-HSA-111997 | 1.043979e-01 | 0.981 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 1.044227e-01 | 0.981 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.044227e-01 | 0.981 | 0 | 0 |
| FasL/ CD95L signaling | R-HSA-75157 | 1.048857e-01 | 0.979 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 1.048857e-01 | 0.979 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 1.048857e-01 | 0.979 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 1.068347e-01 | 0.971 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 1.097702e-01 | 0.960 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.111105e-01 | 0.954 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 1.125368e-01 | 0.949 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 1.147043e-01 | 0.940 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.150730e-01 | 0.939 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 1.150730e-01 | 0.939 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 1.150730e-01 | 0.939 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 1.158009e-01 | 0.936 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.158009e-01 | 0.936 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 1.186395e-01 | 0.926 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.186395e-01 | 0.926 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.186395e-01 | 0.926 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 1.186395e-01 | 0.926 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.213897e-01 | 0.916 | 0 | 0 |
| RSK activation | R-HSA-444257 | 1.213897e-01 | 0.916 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 1.213897e-01 | 0.916 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.213897e-01 | 0.916 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 1.219306e-01 | 0.914 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 1.220439e-01 | 0.913 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 1.224004e-01 | 0.912 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.224004e-01 | 0.912 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 1.228145e-01 | 0.911 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 1.263595e-01 | 0.898 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.272567e-01 | 0.895 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 1.277967e-01 | 0.893 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 1.282120e-01 | 0.892 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 1.282120e-01 | 0.892 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 1.285009e-01 | 0.891 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 1.285009e-01 | 0.891 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 1.293817e-01 | 0.888 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 1.326142e-01 | 0.877 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 1.326142e-01 | 0.877 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 1.326142e-01 | 0.877 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 1.326142e-01 | 0.877 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 1.326142e-01 | 0.877 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.336600e-01 | 0.874 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 1.359390e-01 | 0.867 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.368825e-01 | 0.864 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 1.368825e-01 | 0.864 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 1.368825e-01 | 0.864 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.375242e-01 | 0.862 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 1.375242e-01 | 0.862 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 1.375242e-01 | 0.862 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.380444e-01 | 0.860 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 1.380444e-01 | 0.860 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.966614e-01 | 0.706 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.966614e-01 | 0.706 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.966614e-01 | 0.706 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.966614e-01 | 0.706 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.966614e-01 | 0.706 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.966614e-01 | 0.706 | 0 | 0 |
| RPIA deficiency: failed conversion of RU5P to R5P | R-HSA-6791461 | 1.966614e-01 | 0.706 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.966614e-01 | 0.706 | 0 | 0 |
| RPIA deficiency: failed conversion of R5P to RU5P | R-HSA-5659996 | 1.966614e-01 | 0.706 | 0 | 0 |
| TGFBR2 MSI Frameshift Mutants in Cancer | R-HSA-3642279 | 1.966614e-01 | 0.706 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.966614e-01 | 0.706 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.966614e-01 | 0.706 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 1.409471e-01 | 0.851 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.409471e-01 | 0.851 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 1.409471e-01 | 0.851 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 1.409471e-01 | 0.851 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 1.791585e-01 | 0.747 | 0 | 0 |
| Pentose phosphate pathway disease | R-HSA-6791465 | 2.186868e-01 | 0.660 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 2.186868e-01 | 0.660 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.186868e-01 | 0.660 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 1.720978e-01 | 0.764 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 1.720978e-01 | 0.764 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 1.720978e-01 | 0.764 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 2.588483e-01 | 0.587 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 2.588483e-01 | 0.587 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 2.588483e-01 | 0.587 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 1.575236e-01 | 0.803 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 1.575236e-01 | 0.803 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 1.425085e-01 | 0.846 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 2.275694e-01 | 0.643 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 1.594970e-01 | 0.797 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.003845e-01 | 0.698 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 2.003845e-01 | 0.698 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.564560e-01 | 0.591 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.564560e-01 | 0.591 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.564560e-01 | 0.591 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 1.574690e-01 | 0.803 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 2.229959e-01 | 0.652 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.462264e-01 | 0.609 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 2.462264e-01 | 0.609 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 1.487252e-01 | 0.828 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 1.434654e-01 | 0.843 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.344647e-01 | 0.630 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 2.344647e-01 | 0.630 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 1.962162e-01 | 0.707 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.420061e-01 | 0.848 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 2.290546e-01 | 0.640 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 2.290546e-01 | 0.640 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 2.290546e-01 | 0.640 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 2.422893e-01 | 0.616 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 1.962162e-01 | 0.707 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.577129e-01 | 0.802 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 1.487252e-01 | 0.828 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 1.487252e-01 | 0.828 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 2.297399e-01 | 0.639 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 2.055932e-01 | 0.687 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.685280e-01 | 0.571 | 0 | 0 |
| POLB-Dependent Long Patch Base Excision Repair | R-HSA-110362 | 2.275694e-01 | 0.643 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 1.889888e-01 | 0.724 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 2.275694e-01 | 0.643 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 2.564560e-01 | 0.591 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 2.699517e-01 | 0.569 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 1.559443e-01 | 0.807 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 1.720978e-01 | 0.764 | 0 | 0 |
| G-protein activation | R-HSA-202040 | 1.594970e-01 | 0.797 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 1.426452e-01 | 0.846 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 2.751125e-01 | 0.560 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 2.254717e-01 | 0.647 | 0 | 0 |
| Muscarinic acetylcholine receptors | R-HSA-390648 | 1.791585e-01 | 0.747 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 1.425085e-01 | 0.846 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 1.403899e-01 | 0.853 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 2.751125e-01 | 0.560 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 1.905804e-01 | 0.720 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 2.159887e-01 | 0.666 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 2.545888e-01 | 0.594 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 1.838788e-01 | 0.735 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.758284e-01 | 0.559 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 2.143096e-01 | 0.669 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 1.574690e-01 | 0.803 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 1.810993e-01 | 0.742 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 2.516151e-01 | 0.599 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 2.146825e-01 | 0.668 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 2.146825e-01 | 0.668 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 2.143096e-01 | 0.669 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 2.411117e-01 | 0.618 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 1.815005e-01 | 0.741 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 2.141181e-01 | 0.669 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 2.055932e-01 | 0.687 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 2.411117e-01 | 0.618 | 0 | 0 |
| Inositol transporters | R-HSA-429593 | 1.791585e-01 | 0.747 | 0 | 0 |
| Pyrophosphate hydrolysis | R-HSA-71737 | 1.791585e-01 | 0.747 | 0 | 0 |
| SLC15A4:TASL-dependent IRF5 activation | R-HSA-9860276 | 2.186868e-01 | 0.660 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 1.815005e-01 | 0.741 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 1.815005e-01 | 0.741 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 2.564560e-01 | 0.591 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.402444e-01 | 0.619 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 2.521007e-01 | 0.598 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 2.226955e-01 | 0.652 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 2.516151e-01 | 0.599 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 2.006693e-01 | 0.698 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 2.751125e-01 | 0.560 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.485280e-01 | 0.828 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 1.460161e-01 | 0.836 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 2.186868e-01 | 0.660 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 2.344647e-01 | 0.630 | 0 | 0 |
| Prostacyclin signalling through prostacyclin receptor | R-HSA-392851 | 2.699517e-01 | 0.569 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 1.579787e-01 | 0.801 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 1.782177e-01 | 0.749 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 1.782177e-01 | 0.749 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 1.720978e-01 | 0.764 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.588483e-01 | 0.587 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 1.403899e-01 | 0.853 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 2.344647e-01 | 0.630 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 1.815005e-01 | 0.741 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 1.672699e-01 | 0.777 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 1.425085e-01 | 0.846 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.654467e-01 | 0.576 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 2.258619e-01 | 0.646 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.635264e-01 | 0.786 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 2.573569e-01 | 0.589 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 2.740356e-01 | 0.562 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 2.462264e-01 | 0.609 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 1.962162e-01 | 0.707 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 1.420061e-01 | 0.848 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 2.592268e-01 | 0.586 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 1.428630e-01 | 0.845 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 2.400707e-01 | 0.620 | 0 | 0 |
| Formation of editosomes by ADAR proteins | R-HSA-77042 | 1.966614e-01 | 0.706 | 0 | 0 |
| Inhibition of PKR | R-HSA-169131 | 1.966614e-01 | 0.706 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 1.460161e-01 | 0.836 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 2.564560e-01 | 0.591 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.957234e-01 | 0.708 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 2.462264e-01 | 0.609 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 2.462264e-01 | 0.609 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 1.672699e-01 | 0.777 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 1.546433e-01 | 0.811 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 2.113832e-01 | 0.675 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 2.113832e-01 | 0.675 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.146825e-01 | 0.668 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 2.386129e-01 | 0.622 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 1.517389e-01 | 0.819 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 2.269655e-01 | 0.644 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 2.003845e-01 | 0.698 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 2.564560e-01 | 0.591 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 2.226955e-01 | 0.652 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.474022e-01 | 0.831 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 1.460161e-01 | 0.836 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.772588e-01 | 0.751 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 2.169404e-01 | 0.664 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 1.657597e-01 | 0.781 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.429261e-01 | 0.615 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 2.051809e-01 | 0.688 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.542240e-01 | 0.812 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 2.186868e-01 | 0.660 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 1.993683e-01 | 0.700 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 1.575236e-01 | 0.803 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 1.535566e-01 | 0.814 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 2.581877e-01 | 0.588 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 1.384247e-01 | 0.859 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.720978e-01 | 0.764 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 2.588483e-01 | 0.587 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 2.290546e-01 | 0.640 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 2.592268e-01 | 0.586 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 2.592268e-01 | 0.586 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 2.758284e-01 | 0.559 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 2.686327e-01 | 0.571 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 1.485280e-01 | 0.828 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 2.055932e-01 | 0.687 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 1.943230e-01 | 0.711 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 1.575236e-01 | 0.803 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 1.574690e-01 | 0.803 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 2.764721e-01 | 0.558 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 2.740356e-01 | 0.562 | 0 | 0 |
| Prevention of phagosomal-lysosomal fusion | R-HSA-9636383 | 1.594970e-01 | 0.797 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.972386e-01 | 0.705 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 1.431174e-01 | 0.844 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 1.672699e-01 | 0.777 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 2.429261e-01 | 0.615 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 2.758284e-01 | 0.559 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 1.434654e-01 | 0.843 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 2.462264e-01 | 0.609 | 0 | 0 |
| Suppression of phagosomal maturation | R-HSA-9637687 | 2.751125e-01 | 0.560 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 2.693904e-01 | 0.570 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 1.658557e-01 | 0.780 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 1.610466e-01 | 0.793 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 2.235117e-01 | 0.651 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 1.785183e-01 | 0.748 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.698001e-01 | 0.770 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 1.889888e-01 | 0.724 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.799817e-01 | 0.553 | 0 | 0 |
| IKBKB deficiency causes SCID | R-HSA-5602636 | 2.799817e-01 | 0.553 | 0 | 0 |
| TALDO1 deficiency: failed conversion of SH7P, GA3P to Fru(6)P, E4P | R-HSA-6791055 | 2.799817e-01 | 0.553 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5660724 | 2.799817e-01 | 0.553 | 0 | 0 |
| IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR) | R-HSA-5603027 | 2.799817e-01 | 0.553 | 0 | 0 |
| Defective SLC6A3 causes Parkinsonism-dystonia infantile (PKDYS) | R-HSA-5619081 | 2.799817e-01 | 0.553 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.799817e-01 | 0.553 | 0 | 0 |
| Defective HK1 causes hexokinase deficiency (HK deficiency) | R-HSA-5619056 | 2.799817e-01 | 0.553 | 0 | 0 |
| Defective GFPT1 causes CMSTA1 | R-HSA-4085023 | 2.799817e-01 | 0.553 | 0 | 0 |
| TALDO1 deficiency: failed conversion of Fru(6)P, E4P to SH7P, GA3P | R-HSA-6791462 | 2.799817e-01 | 0.553 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.799817e-01 | 0.553 | 0 | 0 |
| Nef mediated downregulation of CD28 cell surface expression | R-HSA-164939 | 2.799817e-01 | 0.553 | 0 | 0 |
| Transport of connexins along the secretory pathway | R-HSA-190827 | 2.799817e-01 | 0.553 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.799817e-01 | 0.553 | 0 | 0 |
| Defective SERPING1 causes hereditary angioedema | R-HSA-9657689 | 2.799817e-01 | 0.553 | 0 | 0 |
| Oligomerization of connexins into connexons | R-HSA-190704 | 2.799817e-01 | 0.553 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 2.821287e-01 | 0.550 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 2.825355e-01 | 0.549 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 2.825355e-01 | 0.549 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 2.833150e-01 | 0.548 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 2.882907e-01 | 0.540 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.918395e-01 | 0.535 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 2.926916e-01 | 0.534 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.926916e-01 | 0.534 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 2.934116e-01 | 0.533 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 2.940509e-01 | 0.532 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 2.940509e-01 | 0.532 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 2.940509e-01 | 0.532 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 2.940509e-01 | 0.532 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 2.950446e-01 | 0.530 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 2.950446e-01 | 0.530 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 2.959595e-01 | 0.529 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.959595e-01 | 0.529 | 0 | 0 |
| ER Quality Control Compartment (ERQC) | R-HSA-901032 | 2.959595e-01 | 0.529 | 0 | 0 |
| Insulin effects increased synthesis of Xylulose-5-Phosphate | R-HSA-163754 | 2.990869e-01 | 0.524 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 2.990869e-01 | 0.524 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.990869e-01 | 0.524 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 2.990869e-01 | 0.524 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 2.990869e-01 | 0.524 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.990869e-01 | 0.524 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 2.990869e-01 | 0.524 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 2.990869e-01 | 0.524 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.990869e-01 | 0.524 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 2.990869e-01 | 0.524 | 0 | 0 |
| RUNX3 Regulates Immune Response and Cell Migration | R-HSA-8949275 | 2.990869e-01 | 0.524 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 3.005810e-01 | 0.522 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 3.041013e-01 | 0.517 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.097767e-01 | 0.509 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 3.097767e-01 | 0.509 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.111834e-01 | 0.507 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 3.137504e-01 | 0.503 | 0 | 0 |
| Prolactin receptor signaling | R-HSA-1170546 | 3.153860e-01 | 0.501 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 3.153860e-01 | 0.501 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.170546e-01 | 0.499 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 3.170546e-01 | 0.499 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 3.173013e-01 | 0.499 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 3.184073e-01 | 0.497 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 12 | R-HSA-392170 | 3.184073e-01 | 0.497 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 3.184073e-01 | 0.497 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 3.184073e-01 | 0.497 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 3.211813e-01 | 0.493 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 3.220239e-01 | 0.492 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 3.236704e-01 | 0.490 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 3.270442e-01 | 0.485 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.319004e-01 | 0.479 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 3.328420e-01 | 0.478 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 3.328420e-01 | 0.478 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.328420e-01 | 0.478 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 3.372338e-01 | 0.472 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 3.383246e-01 | 0.471 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 3.389551e-01 | 0.470 | 0 | 0 |
| EGFR interacts with phospholipase C-gamma | R-HSA-212718 | 3.389551e-01 | 0.470 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 3.389551e-01 | 0.470 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 3.389551e-01 | 0.470 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.389551e-01 | 0.470 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 3.389551e-01 | 0.470 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.389551e-01 | 0.470 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 3.389551e-01 | 0.470 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 3.389551e-01 | 0.470 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 3.429104e-01 | 0.465 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 3.444548e-01 | 0.463 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 3.450250e-01 | 0.462 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 3.450250e-01 | 0.462 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.450250e-01 | 0.462 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 3.450250e-01 | 0.462 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 3.450250e-01 | 0.462 | 0 | 0 |
| Signaling by Activin | R-HSA-1502540 | 3.450250e-01 | 0.462 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 3.450250e-01 | 0.462 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 3.490635e-01 | 0.457 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 3.493979e-01 | 0.457 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.540257e-01 | 0.451 | 1 | 0 |
| Loss of Function of TGFBR2 in Cancer | R-HSA-3642278 | 3.546647e-01 | 0.450 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.546647e-01 | 0.450 | 0 | 0 |
| TGFBR1 LBD Mutants in Cancer | R-HSA-3656535 | 3.546647e-01 | 0.450 | 0 | 0 |
| TGFBR2 Kinase Domain Mutants in Cancer | R-HSA-3645790 | 3.546647e-01 | 0.450 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.546647e-01 | 0.450 | 0 | 0 |
| Signaling by RAS GAP mutants | R-HSA-9753510 | 3.546647e-01 | 0.450 | 0 | 0 |
| mRNA Editing: A to I Conversion | R-HSA-75064 | 3.546647e-01 | 0.450 | 0 | 0 |
| Defective factor XII causes hereditary angioedema | R-HSA-9657688 | 3.546647e-01 | 0.450 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 3.546647e-01 | 0.450 | 0 | 0 |
| C6 deamination of adenosine | R-HSA-75102 | 3.546647e-01 | 0.450 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 3.579798e-01 | 0.446 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.596989e-01 | 0.444 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 3.596989e-01 | 0.444 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.605330e-01 | 0.443 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 3.619701e-01 | 0.441 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.626841e-01 | 0.440 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 3.651450e-01 | 0.438 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 3.663773e-01 | 0.436 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 3.674556e-01 | 0.435 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.729711e-01 | 0.428 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 3.745424e-01 | 0.426 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 3.745424e-01 | 0.426 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 3.745424e-01 | 0.426 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.780969e-01 | 0.422 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 3.780969e-01 | 0.422 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 3.780969e-01 | 0.422 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 3.780969e-01 | 0.422 | 0 | 0 |
| Estrogen-stimulated signaling through PRKCZ | R-HSA-9634635 | 3.780969e-01 | 0.422 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 3.780969e-01 | 0.422 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 3.780969e-01 | 0.422 | 0 | 0 |
| Zinc influx into cells by the SLC39 gene family | R-HSA-442380 | 3.780969e-01 | 0.422 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 3.780969e-01 | 0.422 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.807435e-01 | 0.419 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 3.839818e-01 | 0.416 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 3.859737e-01 | 0.413 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 3.904007e-01 | 0.408 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 3.910546e-01 | 0.408 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 3.919455e-01 | 0.407 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 3.919455e-01 | 0.407 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 3.919455e-01 | 0.407 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.023151e-01 | 0.395 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.024927e-01 | 0.395 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 4.037840e-01 | 0.394 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 4.037840e-01 | 0.394 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 4.037840e-01 | 0.394 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 4.093082e-01 | 0.388 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 4.096221e-01 | 0.388 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 4.096221e-01 | 0.388 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 4.096221e-01 | 0.388 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 4.096221e-01 | 0.388 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 4.096221e-01 | 0.388 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.118875e-01 | 0.385 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 4.147705e-01 | 0.382 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 4.162343e-01 | 0.381 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 4.162343e-01 | 0.381 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 4.162343e-01 | 0.381 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 4.162343e-01 | 0.381 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 4.162343e-01 | 0.381 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.162898e-01 | 0.381 | 0 | 0 |
| Thromboxane signalling through TP receptor | R-HSA-428930 | 4.162898e-01 | 0.381 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.162898e-01 | 0.381 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 4.204004e-01 | 0.376 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in metabolism | R-HSA-9854907 | 4.216052e-01 | 0.375 | 0 | 0 |
| PLC-gamma1 signalling | R-HSA-167021 | 4.216052e-01 | 0.375 | 0 | 0 |
| Activated NTRK3 signals through PLCG1 | R-HSA-9034793 | 4.216052e-01 | 0.375 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.216052e-01 | 0.375 | 0 | 0 |
| MET activates PTPN11 | R-HSA-8865999 | 4.216052e-01 | 0.375 | 0 | 0 |
| IRAK4 deficiency (TLR5) | R-HSA-5603037 | 4.216052e-01 | 0.375 | 0 | 0 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | R-HSA-392023 | 4.216052e-01 | 0.375 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.216052e-01 | 0.375 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.216052e-01 | 0.375 | 0 | 0 |
| Defective ABCC2 causes DJS | R-HSA-5679001 | 4.216052e-01 | 0.375 | 0 | 0 |
| Intracellular oxygen transport | R-HSA-8981607 | 4.216052e-01 | 0.375 | 0 | 0 |
| Histamine receptors | R-HSA-390650 | 4.216052e-01 | 0.375 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 4.216809e-01 | 0.375 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 4.237870e-01 | 0.373 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 4.237870e-01 | 0.373 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.237870e-01 | 0.373 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 4.240908e-01 | 0.373 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 4.287851e-01 | 0.368 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 4.310298e-01 | 0.365 | 0 | 0 |
| Removal of the Flap Intermediate from the C-strand | R-HSA-174437 | 4.326145e-01 | 0.364 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 4.404059e-01 | 0.356 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 4.404059e-01 | 0.356 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 4.404059e-01 | 0.356 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 4.404059e-01 | 0.356 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 4.404059e-01 | 0.356 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 4.421714e-01 | 0.354 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 4.512258e-01 | 0.346 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 4.522273e-01 | 0.345 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.531547e-01 | 0.344 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 4.531547e-01 | 0.344 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 4.531547e-01 | 0.344 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 4.534694e-01 | 0.343 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 4.609165e-01 | 0.336 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.609165e-01 | 0.336 | 0 | 0 |
| PCNA-Dependent Long Patch Base Excision Repair | R-HSA-5651801 | 4.609165e-01 | 0.336 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 4.609165e-01 | 0.336 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 4.609165e-01 | 0.336 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.609165e-01 | 0.336 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 4.609165e-01 | 0.336 | 0 | 0 |
| Resolution of AP sites via the multiple-nucleotide patch replacement pathway | R-HSA-110373 | 4.642188e-01 | 0.333 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 4.651972e-01 | 0.332 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 4.658859e-01 | 0.332 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 4.658859e-01 | 0.332 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 4.658859e-01 | 0.332 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 4.667696e-01 | 0.331 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 4.672186e-01 | 0.330 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 4.674030e-01 | 0.330 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.674159e-01 | 0.330 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 4.746874e-01 | 0.324 | 0 | 0 |
| MTF1 activates gene expression | R-HSA-5660489 | 4.816054e-01 | 0.317 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 4.816054e-01 | 0.317 | 0 | 0 |
| Activated NTRK2 signals through PLCG1 | R-HSA-9026527 | 4.816054e-01 | 0.317 | 0 | 0 |
| Drug-mediated inhibition of CDK4/CDK6 activity | R-HSA-9754119 | 4.816054e-01 | 0.317 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 4.816054e-01 | 0.317 | 0 | 0 |
| TGFBR1 KD Mutants in Cancer | R-HSA-3656532 | 4.816054e-01 | 0.317 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.816054e-01 | 0.317 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 4.816054e-01 | 0.317 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 4.816054e-01 | 0.317 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 4.816054e-01 | 0.317 | 0 | 0 |
| Activation of NOXA and translocation to mitochondria | R-HSA-111448 | 4.816054e-01 | 0.317 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.816054e-01 | 0.317 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 4.816058e-01 | 0.317 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 4.825204e-01 | 0.316 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 4.834753e-01 | 0.316 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.844731e-01 | 0.315 | 0 | 0 |
| Processive synthesis on the C-strand of the telomere | R-HSA-174414 | 4.876613e-01 | 0.312 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 4.876613e-01 | 0.312 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 4.876613e-01 | 0.312 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 4.876613e-01 | 0.312 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 4.876613e-01 | 0.312 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.885900e-01 | 0.311 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.885900e-01 | 0.311 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 4.885900e-01 | 0.311 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.887003e-01 | 0.311 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 4.887003e-01 | 0.311 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 4.887003e-01 | 0.311 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperone genes | R-HSA-381183 | 4.887003e-01 | 0.311 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.887003e-01 | 0.311 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 4.887003e-01 | 0.311 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 4.890703e-01 | 0.311 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 4.942572e-01 | 0.306 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.958137e-01 | 0.305 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.994195e-01 | 0.302 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 4.994195e-01 | 0.302 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 5.015653e-01 | 0.300 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 5.038490e-01 | 0.298 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 5.040454e-01 | 0.298 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 5.077005e-01 | 0.294 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 5.099200e-01 | 0.292 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 5.106733e-01 | 0.292 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 5.106733e-01 | 0.292 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 5.106733e-01 | 0.292 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 5.106733e-01 | 0.292 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 5.106733e-01 | 0.292 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 5.106733e-01 | 0.292 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 5.106733e-01 | 0.292 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 5.155506e-01 | 0.288 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 5.155506e-01 | 0.288 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 5.217832e-01 | 0.283 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 5.223321e-01 | 0.282 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 5.223321e-01 | 0.282 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 5.227591e-01 | 0.282 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 5.227591e-01 | 0.282 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 5.227591e-01 | 0.282 | 0 | 0 |
| GRB2 events in EGFR signaling | R-HSA-179812 | 5.227591e-01 | 0.282 | 0 | 0 |
| MET activates RAS signaling | R-HSA-8851805 | 5.227591e-01 | 0.282 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.227591e-01 | 0.282 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 5.275589e-01 | 0.278 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.282635e-01 | 0.277 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 5.332023e-01 | 0.273 | 0 | 0 |
| Regulation of MITF-M dependent genes involved in invasion | R-HSA-9854909 | 5.353847e-01 | 0.271 | 0 | 0 |
| IRS activation | R-HSA-74713 | 5.353847e-01 | 0.271 | 0 | 0 |
| Loss of Function of TGFBR1 in Cancer | R-HSA-3656534 | 5.353847e-01 | 0.271 | 0 | 0 |
| SMAD2/3 Phosphorylation Motif Mutants in Cancer | R-HSA-3304356 | 5.353847e-01 | 0.271 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.353847e-01 | 0.271 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 5.353847e-01 | 0.271 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 5.353847e-01 | 0.271 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 5.353847e-01 | 0.271 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 5.353847e-01 | 0.271 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.353847e-01 | 0.271 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 5.353847e-01 | 0.271 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 5.353847e-01 | 0.271 | 0 | 0 |
| Assembly of Viral Components at the Budding Site | R-HSA-168316 | 5.353847e-01 | 0.271 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 5.408634e-01 | 0.267 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.417197e-01 | 0.266 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 5.417292e-01 | 0.266 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 5.417292e-01 | 0.266 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 5.487625e-01 | 0.261 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 5.516140e-01 | 0.258 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 5.552027e-01 | 0.256 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 5.552027e-01 | 0.256 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 5.552570e-01 | 0.256 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 5.552570e-01 | 0.256 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 5.552570e-01 | 0.256 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 5.552570e-01 | 0.256 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 5.552570e-01 | 0.256 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 5.552570e-01 | 0.256 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 5.552570e-01 | 0.256 | 0 | 0 |
| ATF6 (ATF6-alpha) activates chaperones | R-HSA-381033 | 5.552570e-01 | 0.256 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 5.561874e-01 | 0.255 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 5.606754e-01 | 0.251 | 0 | 0 |
| RAS processing | R-HSA-9648002 | 5.660944e-01 | 0.247 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 5.670700e-01 | 0.246 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 5.719056e-01 | 0.243 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 5.754401e-01 | 0.240 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.818442e-01 | 0.235 | 0 | 0 |
| Nef Mediated CD8 Down-regulation | R-HSA-182218 | 5.835876e-01 | 0.234 | 0 | 0 |
| Signaling by Overexpressed Wild-Type EGFR in Cancer | R-HSA-5638302 | 5.835876e-01 | 0.234 | 0 | 0 |
| Inhibition of Signaling by Overexpressed EGFR | R-HSA-5638303 | 5.835876e-01 | 0.234 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.835876e-01 | 0.234 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.835876e-01 | 0.234 | 0 | 0 |
| TRAIL signaling | R-HSA-75158 | 5.835876e-01 | 0.234 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 5.835876e-01 | 0.234 | 0 | 0 |
| Loss of Function of SMAD2/3 in Cancer | R-HSA-3304349 | 5.835876e-01 | 0.234 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.835876e-01 | 0.234 | 0 | 0 |
| Orexin and neuropeptides FF and QRFP bind to their respective receptors | R-HSA-389397 | 5.835876e-01 | 0.234 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.835876e-01 | 0.234 | 0 | 0 |
| Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660825 | 5.835876e-01 | 0.234 | 0 | 0 |
| Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant | R-HSA-2660826 | 5.835876e-01 | 0.234 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.835876e-01 | 0.234 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 5.849722e-01 | 0.233 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 5.861514e-01 | 0.232 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 5.861514e-01 | 0.232 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.861514e-01 | 0.232 | 0 | 0 |
| Zinc transporters | R-HSA-435354 | 5.861514e-01 | 0.232 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.898300e-01 | 0.229 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.915299e-01 | 0.228 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 5.915299e-01 | 0.228 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 5.915299e-01 | 0.228 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 5.915299e-01 | 0.228 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 5.924774e-01 | 0.227 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 5.974688e-01 | 0.224 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 5.974688e-01 | 0.224 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 5.980761e-01 | 0.223 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 5.981755e-01 | 0.223 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 5.993628e-01 | 0.222 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 5.993628e-01 | 0.222 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 6.079401e-01 | 0.216 | 0 | 0 |
| Response of EIF2AK1 (HRI) to heme deficiency | R-HSA-9648895 | 6.150770e-01 | 0.211 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 6.150770e-01 | 0.211 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 6.154252e-01 | 0.211 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 6.154252e-01 | 0.211 | 0 | 0 |
| SHC1 events in EGFR signaling | R-HSA-180336 | 6.154252e-01 | 0.211 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 6.154252e-01 | 0.211 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 6.154252e-01 | 0.211 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 6.176754e-01 | 0.209 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 6.213429e-01 | 0.207 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 6.213429e-01 | 0.207 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 6.227890e-01 | 0.206 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 6.245546e-01 | 0.204 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 6.267922e-01 | 0.203 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.267922e-01 | 0.203 | 0 | 0 |
| Defective SLC16A1 causes symptomatic deficiency in lactate transport (SDLT) | R-HSA-5619070 | 6.267922e-01 | 0.203 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.267922e-01 | 0.203 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 6.267922e-01 | 0.203 | 0 | 0 |
| Defective CHST14 causes EDS, musculocontractural type | R-HSA-3595174 | 6.267922e-01 | 0.203 | 0 | 0 |
| Defective CHST3 causes SEDCJD | R-HSA-3595172 | 6.267922e-01 | 0.203 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex in Cancer | R-HSA-3304351 | 6.267922e-01 | 0.203 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 6.267922e-01 | 0.203 | 0 | 0 |
| Abacavir transmembrane transport | R-HSA-2161517 | 6.267922e-01 | 0.203 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 6.267922e-01 | 0.203 | 0 | 0 |
| CREB3 factors activate genes | R-HSA-8874211 | 6.267922e-01 | 0.203 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 6.318702e-01 | 0.199 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 6.362903e-01 | 0.196 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.372346e-01 | 0.196 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 6.372346e-01 | 0.196 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 6.387973e-01 | 0.195 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 6.430820e-01 | 0.192 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 6.430820e-01 | 0.192 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 6.430820e-01 | 0.192 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 6.430820e-01 | 0.192 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 6.430820e-01 | 0.192 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 6.464690e-01 | 0.189 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.476261e-01 | 0.189 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 6.557443e-01 | 0.183 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 6.557443e-01 | 0.183 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 6.560769e-01 | 0.183 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.593540e-01 | 0.181 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 6.614762e-01 | 0.179 | 0 | 0 |
| MET activates PI3K/AKT signaling | R-HSA-8851907 | 6.655163e-01 | 0.177 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 6.655163e-01 | 0.177 | 0 | 0 |
| Defective CHSY1 causes TPBS | R-HSA-3595177 | 6.655163e-01 | 0.177 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.655163e-01 | 0.177 | 0 | 0 |
| Nef Mediated CD4 Down-regulation | R-HSA-167590 | 6.655163e-01 | 0.177 | 0 | 0 |
| TGFBR3 regulates TGF-beta signaling | R-HSA-9839389 | 6.655163e-01 | 0.177 | 0 | 0 |
| Synthesis of PIPs in the nucleus | R-HSA-8847453 | 6.655163e-01 | 0.177 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 6.655163e-01 | 0.177 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.655163e-01 | 0.177 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 6.655163e-01 | 0.177 | 0 | 0 |
| Maturation of replicase proteins | R-HSA-9694301 | 6.655163e-01 | 0.177 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 6.691423e-01 | 0.174 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 6.691423e-01 | 0.174 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 6.691423e-01 | 0.174 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.691423e-01 | 0.174 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 6.691423e-01 | 0.174 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 6.721726e-01 | 0.173 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 6.727897e-01 | 0.172 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.740653e-01 | 0.171 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 6.782355e-01 | 0.169 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.800660e-01 | 0.167 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 6.800660e-01 | 0.167 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.858685e-01 | 0.164 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 6.880742e-01 | 0.162 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.918938e-01 | 0.160 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 6.936395e-01 | 0.159 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.936395e-01 | 0.159 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 6.936395e-01 | 0.159 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.936395e-01 | 0.159 | 0 | 0 |
| Sulfide oxidation to sulfate | R-HSA-1614517 | 6.936395e-01 | 0.159 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 6.936395e-01 | 0.159 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 6.936395e-01 | 0.159 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 6.936395e-01 | 0.159 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 6.998270e-01 | 0.155 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.998270e-01 | 0.155 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 6.998270e-01 | 0.155 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 7.002245e-01 | 0.155 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.002245e-01 | 0.155 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 7.002245e-01 | 0.155 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 7.002245e-01 | 0.155 | 0 | 0 |
| Activated NTRK2 signals through PI3K | R-HSA-9028335 | 7.002245e-01 | 0.155 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 7.002245e-01 | 0.155 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 7.002245e-01 | 0.155 | 0 | 0 |
| Activation of RAS in B cells | R-HSA-1169092 | 7.002245e-01 | 0.155 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.002245e-01 | 0.155 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 7.002245e-01 | 0.155 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 7.002245e-01 | 0.155 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 7.002245e-01 | 0.155 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 7.023264e-01 | 0.153 | 1 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 7.034433e-01 | 0.153 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 7.034433e-01 | 0.153 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 7.123322e-01 | 0.147 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 7.166174e-01 | 0.145 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 7.166174e-01 | 0.145 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 7.166174e-01 | 0.145 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 7.166174e-01 | 0.145 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 7.166174e-01 | 0.145 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 7.182771e-01 | 0.144 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 7.186451e-01 | 0.143 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 7.249262e-01 | 0.140 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.296231e-01 | 0.137 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 7.313329e-01 | 0.136 | 0 | 0 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 7.313329e-01 | 0.136 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 7.313329e-01 | 0.136 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 7.313329e-01 | 0.136 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 7.313329e-01 | 0.136 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.313329e-01 | 0.136 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 7.313329e-01 | 0.136 | 0 | 0 |
| mRNA Editing | R-HSA-75072 | 7.313329e-01 | 0.136 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 7.313329e-01 | 0.136 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.313329e-01 | 0.136 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.313329e-01 | 0.136 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 7.313329e-01 | 0.136 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 7.313329e-01 | 0.136 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 7.313329e-01 | 0.136 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.333791e-01 | 0.135 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 7.365330e-01 | 0.133 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 7.365330e-01 | 0.133 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 7.381274e-01 | 0.132 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 7.381274e-01 | 0.132 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 7.404224e-01 | 0.131 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.404224e-01 | 0.131 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 7.404224e-01 | 0.131 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 7.457591e-01 | 0.127 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 7.535082e-01 | 0.123 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 7.535082e-01 | 0.123 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 7.535082e-01 | 0.123 | 0 | 0 |
| Formation of ATP by chemiosmotic coupling | R-HSA-163210 | 7.582268e-01 | 0.120 | 0 | 0 |
| Mitochondrial iron-sulfur cluster biogenesis | R-HSA-1362409 | 7.582268e-01 | 0.120 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 7.592148e-01 | 0.120 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 7.592148e-01 | 0.120 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 7.592148e-01 | 0.120 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 7.592148e-01 | 0.120 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.592148e-01 | 0.120 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.592148e-01 | 0.120 | 0 | 0 |
| Interleukin-27 signaling | R-HSA-9020956 | 7.592148e-01 | 0.120 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 7.592148e-01 | 0.120 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 7.592148e-01 | 0.120 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 7.600325e-01 | 0.119 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.650385e-01 | 0.116 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 7.769765e-01 | 0.110 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 7.769765e-01 | 0.110 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.769765e-01 | 0.110 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 7.816266e-01 | 0.107 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 7.829199e-01 | 0.106 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.829199e-01 | 0.106 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 7.842046e-01 | 0.106 | 0 | 0 |
| vRNA Synthesis | R-HSA-192814 | 7.842046e-01 | 0.106 | 0 | 0 |
| Propionyl-CoA catabolism | R-HSA-71032 | 7.842046e-01 | 0.106 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.842046e-01 | 0.106 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.842046e-01 | 0.106 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.842046e-01 | 0.106 | 0 | 0 |
| Activated NTRK3 signals through RAS | R-HSA-9034864 | 7.842046e-01 | 0.106 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.842046e-01 | 0.106 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.842046e-01 | 0.106 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.842046e-01 | 0.106 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.842046e-01 | 0.106 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.848067e-01 | 0.105 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 7.890472e-01 | 0.103 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 7.944402e-01 | 0.100 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 7.944402e-01 | 0.100 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 7.957934e-01 | 0.099 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 7.957934e-01 | 0.099 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 7.991802e-01 | 0.097 | 0 | 0 |
| DS-GAG biosynthesis | R-HSA-2022923 | 8.066022e-01 | 0.093 | 0 | 0 |
| Proton-coupled monocarboxylate transport | R-HSA-433692 | 8.066022e-01 | 0.093 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 8.066022e-01 | 0.093 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 8.066022e-01 | 0.093 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 8.066022e-01 | 0.093 | 0 | 0 |
| Reduction of cytosolic Ca++ levels | R-HSA-418359 | 8.066022e-01 | 0.093 | 0 | 0 |
| Activated NTRK2 signals through RAS | R-HSA-9026519 | 8.066022e-01 | 0.093 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 8.066022e-01 | 0.093 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.071415e-01 | 0.093 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 8.096437e-01 | 0.092 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 8.106827e-01 | 0.091 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 8.106827e-01 | 0.091 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 8.106827e-01 | 0.091 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.127402e-01 | 0.090 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 8.127402e-01 | 0.090 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 8.127402e-01 | 0.090 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.142306e-01 | 0.089 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 8.189409e-01 | 0.087 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.196893e-01 | 0.086 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.220765e-01 | 0.085 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 8.255161e-01 | 0.083 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 8.255161e-01 | 0.083 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 8.257694e-01 | 0.083 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 8.257694e-01 | 0.083 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.257694e-01 | 0.083 | 0 | 0 |
| Synthesis of UDP-N-acetyl-glucosamine | R-HSA-446210 | 8.257694e-01 | 0.083 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.266763e-01 | 0.083 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 8.266763e-01 | 0.083 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 8.266763e-01 | 0.083 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.266763e-01 | 0.083 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.266763e-01 | 0.083 | 0 | 0 |
| Trafficking and processing of endosomal TLR | R-HSA-1679131 | 8.266763e-01 | 0.083 | 0 | 0 |
| Synthesis of GDP-mannose | R-HSA-446205 | 8.266763e-01 | 0.083 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.266763e-01 | 0.083 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.266763e-01 | 0.083 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 8.266763e-01 | 0.083 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 8.266763e-01 | 0.083 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.266763e-01 | 0.083 | 0 | 0 |
| Interleukin-35 Signalling | R-HSA-8984722 | 8.266763e-01 | 0.083 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 8.281030e-01 | 0.082 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 8.307453e-01 | 0.081 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 8.340003e-01 | 0.079 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 8.375386e-01 | 0.077 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 8.375386e-01 | 0.077 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 8.375386e-01 | 0.077 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 8.379090e-01 | 0.077 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.397652e-01 | 0.076 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.397652e-01 | 0.076 | 0 | 0 |
| Mitochondrial RNA degradation | R-HSA-9836573 | 8.397652e-01 | 0.076 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 8.414681e-01 | 0.075 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 8.427695e-01 | 0.074 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.446678e-01 | 0.073 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.446678e-01 | 0.073 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.446678e-01 | 0.073 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 8.446678e-01 | 0.073 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 8.446678e-01 | 0.073 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.446678e-01 | 0.073 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 8.468986e-01 | 0.072 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 8.469699e-01 | 0.072 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.471808e-01 | 0.072 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 8.527339e-01 | 0.069 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.527339e-01 | 0.069 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 8.527339e-01 | 0.069 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.527339e-01 | 0.069 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 8.539974e-01 | 0.069 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 8.560091e-01 | 0.068 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 8.576746e-01 | 0.067 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 8.594485e-01 | 0.066 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.605664e-01 | 0.065 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.607927e-01 | 0.065 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR3 | R-HSA-5654227 | 8.607927e-01 | 0.065 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.607927e-01 | 0.065 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 8.607927e-01 | 0.065 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 8.607927e-01 | 0.065 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 8.607927e-01 | 0.065 | 0 | 0 |
| Malate-aspartate shuttle | R-HSA-9856872 | 8.607927e-01 | 0.065 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 8.607927e-01 | 0.065 | 0 | 0 |
| Ciprofloxacin ADME | R-HSA-9793528 | 8.607927e-01 | 0.065 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 8.607927e-01 | 0.065 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.607927e-01 | 0.065 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 8.644076e-01 | 0.063 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.647380e-01 | 0.063 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.647380e-01 | 0.063 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 8.647380e-01 | 0.063 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 8.647380e-01 | 0.063 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 8.682213e-01 | 0.061 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.693053e-01 | 0.061 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 8.693990e-01 | 0.061 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.752445e-01 | 0.058 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR4 | R-HSA-5654228 | 8.752445e-01 | 0.058 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 8.752445e-01 | 0.058 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.752445e-01 | 0.058 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.752445e-01 | 0.058 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 8.752445e-01 | 0.058 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.752445e-01 | 0.058 | 0 | 0 |
| Dopamine clearance from the synaptic cleft | R-HSA-379401 | 8.752445e-01 | 0.058 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.752445e-01 | 0.058 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.752445e-01 | 0.058 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 8.752445e-01 | 0.058 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 8.758378e-01 | 0.058 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 8.758378e-01 | 0.058 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 8.758378e-01 | 0.058 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.778529e-01 | 0.057 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 8.785831e-01 | 0.056 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 8.787219e-01 | 0.056 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 8.799705e-01 | 0.056 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 8.857775e-01 | 0.053 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 8.860917e-01 | 0.053 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 8.860917e-01 | 0.053 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.874484e-01 | 0.052 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.874484e-01 | 0.052 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 8.874484e-01 | 0.052 | 0 | 0 |
| Mitochondrial tRNA aminoacylation | R-HSA-379726 | 8.874484e-01 | 0.052 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.881968e-01 | 0.051 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.881968e-01 | 0.051 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 8.881968e-01 | 0.051 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 8.881968e-01 | 0.051 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.881968e-01 | 0.051 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.881968e-01 | 0.051 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.881968e-01 | 0.051 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.881968e-01 | 0.051 | 0 | 0 |
| Atorvastatin ADME | R-HSA-9754706 | 8.881968e-01 | 0.051 | 0 | 0 |
| Virus Assembly and Release | R-HSA-168268 | 8.881968e-01 | 0.051 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 8.901112e-01 | 0.051 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.932498e-01 | 0.049 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 8.939826e-01 | 0.049 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 8.955556e-01 | 0.048 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 8.955556e-01 | 0.048 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.955556e-01 | 0.048 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.955556e-01 | 0.048 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 8.955556e-01 | 0.048 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 8.972406e-01 | 0.047 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.998050e-01 | 0.046 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.998050e-01 | 0.046 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.998050e-01 | 0.046 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 8.998050e-01 | 0.046 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 8.998050e-01 | 0.046 | 0 | 0 |
| SHC1 events in ERBB4 signaling | R-HSA-1250347 | 8.998050e-01 | 0.046 | 0 | 0 |
| Response to metal ions | R-HSA-5660526 | 8.998050e-01 | 0.046 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.001904e-01 | 0.046 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.005624e-01 | 0.045 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.022707e-01 | 0.045 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.022707e-01 | 0.045 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 9.032332e-01 | 0.044 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 9.032332e-01 | 0.044 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 9.032332e-01 | 0.044 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 9.042831e-01 | 0.044 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.042831e-01 | 0.044 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.042831e-01 | 0.044 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 9.042831e-01 | 0.044 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 9.072151e-01 | 0.042 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.086914e-01 | 0.042 | 0 | 0 |
| Phospholipase C-mediated cascade: FGFR1 | R-HSA-5654219 | 9.102086e-01 | 0.041 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 9.102086e-01 | 0.041 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 9.102086e-01 | 0.041 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 9.102086e-01 | 0.041 | 0 | 0 |
| Metabolism of ingested H2SeO4 and H2SeO3 into H2Se | R-HSA-2408550 | 9.102086e-01 | 0.041 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 9.102086e-01 | 0.041 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 9.103506e-01 | 0.041 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.103506e-01 | 0.041 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.103506e-01 | 0.041 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 9.123249e-01 | 0.040 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.123249e-01 | 0.040 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.123426e-01 | 0.040 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 9.169893e-01 | 0.038 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 9.169893e-01 | 0.038 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.191867e-01 | 0.037 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.195325e-01 | 0.036 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.197293e-01 | 0.036 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.228251e-01 | 0.035 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.228251e-01 | 0.035 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.228251e-01 | 0.035 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.231489e-01 | 0.035 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.233041e-01 | 0.035 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 9.265420e-01 | 0.033 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.278887e-01 | 0.033 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 9.278887e-01 | 0.033 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 9.278887e-01 | 0.033 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 9.278887e-01 | 0.033 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 9.278887e-01 | 0.033 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.278887e-01 | 0.033 | 0 | 0 |
| Other interleukin signaling | R-HSA-449836 | 9.278887e-01 | 0.033 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.278887e-01 | 0.033 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.286252e-01 | 0.032 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.286252e-01 | 0.032 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.289388e-01 | 0.032 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.296926e-01 | 0.032 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.320390e-01 | 0.031 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.328060e-01 | 0.030 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.328060e-01 | 0.030 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.343011e-01 | 0.030 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.343011e-01 | 0.030 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.345128e-01 | 0.029 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 9.353776e-01 | 0.029 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.353776e-01 | 0.029 | 0 | 0 |
| Phospholipase C-mediated cascade; FGFR2 | R-HSA-5654221 | 9.353776e-01 | 0.029 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 9.353776e-01 | 0.029 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 9.353776e-01 | 0.029 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.390502e-01 | 0.027 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.390502e-01 | 0.027 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.392233e-01 | 0.027 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.420892e-01 | 0.026 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 9.420892e-01 | 0.026 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 9.420892e-01 | 0.026 | 0 | 0 |
| SHC-mediated cascade:FGFR3 | R-HSA-5654704 | 9.420892e-01 | 0.026 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.420892e-01 | 0.026 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 9.420892e-01 | 0.026 | 0 | 0 |
| Vitamin C (ascorbate) metabolism | R-HSA-196836 | 9.420892e-01 | 0.026 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 9.420892e-01 | 0.026 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 9.432996e-01 | 0.025 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.432996e-01 | 0.025 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 9.436695e-01 | 0.025 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.438471e-01 | 0.025 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.438471e-01 | 0.025 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 9.439221e-01 | 0.025 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.439221e-01 | 0.025 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.442816e-01 | 0.025 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.456378e-01 | 0.024 | 0 | 0 |
| CS-GAG biosynthesis | R-HSA-2022870 | 9.481040e-01 | 0.023 | 0 | 0 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 9.481040e-01 | 0.023 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.481040e-01 | 0.023 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.481040e-01 | 0.023 | 0 | 0 |
| Serine metabolism | R-HSA-977347 | 9.481040e-01 | 0.023 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.486978e-01 | 0.023 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 9.510882e-01 | 0.022 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.531470e-01 | 0.021 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.531470e-01 | 0.021 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.531470e-01 | 0.021 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.531470e-01 | 0.021 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 9.534945e-01 | 0.021 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.534945e-01 | 0.021 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 9.534945e-01 | 0.021 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.534945e-01 | 0.021 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.534945e-01 | 0.021 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.534945e-01 | 0.021 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.534945e-01 | 0.021 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 9.544740e-01 | 0.020 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.557786e-01 | 0.020 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.572258e-01 | 0.019 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.572258e-01 | 0.019 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.572258e-01 | 0.019 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 9.577225e-01 | 0.019 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.582103e-01 | 0.019 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 9.583253e-01 | 0.018 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.583253e-01 | 0.018 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.583253e-01 | 0.018 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.586647e-01 | 0.018 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.609631e-01 | 0.017 | 0 | 0 |
| Translocation of ZAP-70 to Immunological synapse | R-HSA-202430 | 9.626546e-01 | 0.017 | 0 | 0 |
| SHC-mediated cascade:FGFR1 | R-HSA-5654688 | 9.626546e-01 | 0.017 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.626546e-01 | 0.017 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.626546e-01 | 0.017 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.631152e-01 | 0.016 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.632813e-01 | 0.016 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 9.636935e-01 | 0.016 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.643859e-01 | 0.016 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.654891e-01 | 0.015 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.664613e-01 | 0.015 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.665343e-01 | 0.015 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.665343e-01 | 0.015 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.665343e-01 | 0.015 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.665343e-01 | 0.015 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 9.665343e-01 | 0.015 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.665343e-01 | 0.015 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 9.665343e-01 | 0.015 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 9.675190e-01 | 0.014 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.682161e-01 | 0.014 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.700112e-01 | 0.013 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.700112e-01 | 0.013 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.700112e-01 | 0.013 | 0 | 0 |
| Abacavir ADME | R-HSA-2161522 | 9.700112e-01 | 0.013 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 9.703776e-01 | 0.013 | 0 | 0 |
| Scavenging by Class A Receptors | R-HSA-3000480 | 9.703858e-01 | 0.013 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 9.703858e-01 | 0.013 | 0 | 0 |
| Heme biosynthesis | R-HSA-189451 | 9.703858e-01 | 0.013 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.709782e-01 | 0.013 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.730705e-01 | 0.012 | 0 | 0 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 9.731271e-01 | 0.012 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.731271e-01 | 0.012 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 9.731271e-01 | 0.012 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 9.731271e-01 | 0.012 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 9.731271e-01 | 0.012 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.731271e-01 | 0.012 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.759194e-01 | 0.011 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 9.759194e-01 | 0.011 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.760399e-01 | 0.011 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.775953e-01 | 0.010 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.775953e-01 | 0.010 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.784217e-01 | 0.009 | 0 | 0 |
| Degradation of cysteine and homocysteine | R-HSA-1614558 | 9.795963e-01 | 0.009 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 9.814235e-01 | 0.008 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.826736e-01 | 0.008 | 0 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.829581e-01 | 0.007 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.829581e-01 | 0.007 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.834026e-01 | 0.007 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.845862e-01 | 0.007 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 9.854266e-01 | 0.006 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 9.854266e-01 | 0.006 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 9.854266e-01 | 0.006 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.860019e-01 | 0.006 | 0 | 0 |
| Diseases associated with glycosylation precursor biosynthesis | R-HSA-5609975 | 9.860880e-01 | 0.006 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.860880e-01 | 0.006 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.871950e-01 | 0.006 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.871950e-01 | 0.006 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 9.872681e-01 | 0.006 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.874364e-01 | 0.005 | 0 | 0 |
| CS/DS degradation | R-HSA-2024101 | 9.875341e-01 | 0.005 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.875341e-01 | 0.005 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 9.884223e-01 | 0.005 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.888299e-01 | 0.005 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.888299e-01 | 0.005 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.888299e-01 | 0.005 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.888299e-01 | 0.005 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.888299e-01 | 0.005 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.888299e-01 | 0.005 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.894743e-01 | 0.005 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.899911e-01 | 0.004 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 9.904327e-01 | 0.004 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.910316e-01 | 0.004 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 9.910316e-01 | 0.004 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.910316e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.911165e-01 | 0.004 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.914156e-01 | 0.004 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.918592e-01 | 0.004 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.918592e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.919641e-01 | 0.004 | 0 | 0 |
| Beta-oxidation of very long chain fatty acids | R-HSA-390247 | 9.919641e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.919641e-01 | 0.004 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.924308e-01 | 0.003 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.931536e-01 | 0.003 | 0 | 0 |
| Aspirin ADME | R-HSA-9749641 | 9.931689e-01 | 0.003 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.935483e-01 | 0.003 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.940823e-01 | 0.003 | 0 | 0 |
| Tryptophan catabolism | R-HSA-71240 | 9.942192e-01 | 0.003 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.942192e-01 | 0.003 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.942238e-01 | 0.003 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.945504e-01 | 0.002 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 9.946275e-01 | 0.002 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.946275e-01 | 0.002 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.948203e-01 | 0.002 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 9.948203e-01 | 0.002 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.948203e-01 | 0.002 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.951234e-01 | 0.002 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.951620e-01 | 0.002 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.955662e-01 | 0.002 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.955742e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.956125e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.956125e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.958417e-01 | 0.002 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.964061e-01 | 0.002 | 0 | 0 |
| Methylation | R-HSA-156581 | 9.966618e-01 | 0.001 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.970090e-01 | 0.001 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.970203e-01 | 0.001 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.975990e-01 | 0.001 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 9.977659e-01 | 0.001 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.977874e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.983370e-01 | 0.001 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.984008e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.984529e-01 | 0.001 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.984529e-01 | 0.001 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.986421e-01 | 0.001 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 9.987581e-01 | 0.001 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.988803e-01 | 0.000 | 0 | 0 |
| Chondroitin sulfate/dermatan sulfate metabolism | R-HSA-1793185 | 9.990032e-01 | 0.000 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.990630e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.991457e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.991527e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.992323e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.992975e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.993532e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.993558e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.994499e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.994536e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.994631e-01 | 0.000 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.994846e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.995110e-01 | 0.000 | 0 | 0 |
| Peroxisomal lipid metabolism | R-HSA-390918 | 9.995434e-01 | 0.000 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.995863e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid biosynthesis | R-HSA-9840309 | 9.996294e-01 | 0.000 | 0 | 0 |
| Sulfur amino acid metabolism | R-HSA-1614635 | 9.996620e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.996638e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.996924e-01 | 0.000 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.997336e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.997496e-01 | 0.000 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.997613e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.997613e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.998264e-01 | 0.000 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.998284e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.998463e-01 | 0.000 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.998463e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.998479e-01 | 0.000 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.998637e-01 | 0.000 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.998660e-01 | 0.000 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.998767e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.998768e-01 | 0.000 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.998860e-01 | 0.000 | 0 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.998860e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.999206e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.999243e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.999251e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.999289e-01 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 9.999479e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999607e-01 | 0.000 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.999660e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999710e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999804e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999858e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999865e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999882e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999888e-01 | 0.000 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.999894e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999921e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999935e-01 | 0.000 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.999969e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999971e-01 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.999980e-01 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 9.999991e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999992e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999997e-01 | 0.000 | 0 | 0 |
| Glycosphingolipid metabolism | R-HSA-1660662 | 9.999997e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.999997e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999999e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999999e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999999e-01 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 1.000000e+00 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |